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The primary objective of this dissertation is to address a number of key challenges and issues in 
the detection, resequencing and evolutionary analysis of viruses. Using novel ideas to improve 
upon existing approaches, it aims to develop better technologies and bioinformatics tools that 
would have a greater impact on clinical decision-making. 
 Amplification of viral genomes is a necessary first step of diagnosis and sequence 
analysis. The thesis explores the pitfalls of using specific primers for amplification and proposes 
to use random-tagged primers, particularly for amplification of unknown viruses. Although it is 
theoretically possible for random-tagged primers to bind to any sequence, the blind use of such 
primers without careful design does not guarantee genome-wide amplification of the virus. In the 
second chapter, the thesis introduces a model to predict amplification efficiency of random-
tagged primers and developed an algorithm, LOMA, to design random-tagged primers with 
optimal amplification efficiency. Experiments show that the random-tagged primers generated 
by LOMA can amplify up to 90% of the genomes of the target viruses. 
 In the third chapter, the thesis argues the advantages of using DNA microarrays for 
diagnostics over traditional PCR methods. To increase the sensitivity and specificity of 
microarray diagnostics, the thesis makes use of random-tagged primers for amplification and 
proposes an algorithm (PDA) that analyzes the distribution of probe signal intensities of in-silico 
recognition signatures probe sets of each virus based on a novel weighted Kullback-Leibler 
divergence that is sensitive to the tail of the distribution. Validation experiments show that PDA 
is able to accurately detect and identify co-infections of multiple viruses, as well as unknown 
viruses initially missed by PCR tests. 
VII 
 In the fourth chapter, the thesis demonstrates the feasibility of using resequencing 
microarrays as a large scale bio-surveillance tool. In the wake of the 2009 H1N1 influenza 
pandemic, a novel resequencing kit that is capable of interrogating all eight segments of the 
H1N1 2009 influenza, with accommodation for mutation hotspots, was developed. The 
accompanying base-calling software EvolSTAR is a new method that utilizes neighbourhood 
hybridization intensity profiles and substitution bias of probes on the microarray for mutation 
confirmation and recovery of ambiguous base queries. Validation experiments show that 
EvolSTAR can achieve a much higher accuracy and call rate than existing competing methods. 
 The fifth chapter discusses the role that recombination plays in the emergence of novel or 
more virulent strains of viral pathogens. Understanding the mechanisms of viral evolution will 
aid in the development of better anti-viral drugs, vaccines, as well as diagnostics and surveillance 
tools. The thesis presents an algorithm (RB-Finder) that uses a more informative distance metric 
that overcomes the inaccuracies of methods that uses base-by-base comparisons. Experiments 
show that RB-Finder is able to achieve accuracies comparable to the most accurate phylogeny-
based methods but within a much shorter time. In addition, RB-Finder is able to distinguish 
regions of high mutation rates from recombination breakpoints. 
 In summary, the thesis has contributed several technologies and novel methods that have 
significantly improved existing bioinformatics approaches in virology research.  
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1.1 The Threat of Human Viruses 
Viruses are one of the main classes of microscopic agents which cause infectious disease in 
humans. They are made up of genetic material known as DNA or RNA and require a host to 
survive. By means of proteins on its outermost surface, a virus can recognize and attach itself to 
the appropriate host cells. The virus then multiplies by tricking the healthy cell to duplicate the 
viral nucleic acid as well as enzymes needed by the virus for enveloping and coat protein 
formation, killing or altering the functions of the cell in the process. New viruses are released via 
lysis of the host cells and begin infecting other cells, causing disease. 
 Viruses have the potential to spread rapidly in a locality or even worldwide and infect a 
large proportion of the human population. One of the most widespread disease affecting humans 
is influenza, commonly referred to as the flu, caused by RNA viruses of the family 
Orthomyxoviridae. They affect millions of people and result in the deaths of hundreds of 
thousands worldwide annually. However, there is another virus, the human immunodeficiency 
virus (HIV) that causes acquired immunodeficiency syndrome (AIDS) in humans and it has 
become one of the most serious health threat to the human population over the last few decades. 
Believed to have originated from non-human primates [1], HIV targets the T cells of the immune 
system, severely weakening it. As the immune system weakens, common organisms such as 
bacteria and viruses become fatal as the body can no longer defend against them. Since its 
discovery in 1981, AIDS has infected an estimated 33.4 million people and killed more than 25 
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million people [2]. Besides causing diseases, viruses are also responsible for certain cancers. 
Recently, a new virus, Merkel cell polyomavirus, has been identified to cause cancer in humans 
[3]. This adds to the list of five other cancer-linked viruses: papillomaviruses [4], human T-
lymphotropic virus Type I [5], hepatitis B virus [6], Epstein-Barr virus [7] and Kaposi’s Sarcoma 
Herpesvirus [8]. While there is much circumstantial evidence that viruses can cause certain types 
of cancer, it is still unclear exactly how viruses trigger cancer. It is most likely that tumors are 
formed when viruses integrated their genetic material with that of the host cells [9].  
To reduce disease mortality and risk of certain cancers in humans, early detection of viral 
infections is vital. As such, there has been continual development of virological tests to provide 
fast, accurate and cost-effective diagnosis. So far, these virological tests have proven to be 
essential for the management of viral infections and administration of treatment. 
 The genetic arms race between viruses and host cells is never-ending. As host cells 
produce stronger immune responses to counteract the invading viruses, viruses evolve to enhance 
their ability to infect. Mechanisms of viral evolution include point mutations, genome 
rearrangements, as well as recombination and translocation events that may result in gene 
acquisition, gene creation and gene deletion [10]. As viruses evolve, they may become new 
variants or novel viruses with unpredictable virulence. In some cases, these new viruses become 
so virulent that they resulted in pandemics with high levels of mortality. For example, influenza 
viruses evolve into new strains almost yearly via mutations or re-assortment of their genes with 
other flu viruses. One such new strain of influenza A virus of subtype H1N1 is responsible for 
the 1918 Spanish flu pandemic, the worst pandemic in history that resulted in the deaths of over 
50 million people [11]. Other notable influenza pandemics include the 1957 Asian flu pandemic, 
1968 Hong Kong flu pandemic and most recently, the 2009 H1N1 pandemic. Besides influenza, 
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other novel or mutant viruses can also cause serious viral outbreaks. In 2003, a novel coronavirus 
emerged from the Guangdong province in China and caused the Severe Acute Respiratory 
Syndrome (SARS) outbreak that claimed the lives of 774 individuals in 37 countries around the 
world in a matter of weeks [12]. Based on historical data since 1901, studies have shown that on 
average, more than two new species of human virus are reported every year [13]. By fitting a 
statistical model to these data, it is predicted that 10 to 40 new species of virus will be discovered 
by 2020 [14]. As such, the health threat that these new viruses will present cannot be overlooked.  
Early detection and continual biosurveillance of viruses, as well as understanding their 
evolution, are the solutions for preventing viral pandemics and controlling emerging infectious 
diseases. Over the years, a myriad of technology and methods have been developed to detect, 
obtain and analyze the genetic information of viruses to understand their virulence and evolution. 
This thesis presents new tools and methods that improve upon existing approaches. 
 
1.2 Diagnostic and Detection of Viruses 
In viral diagnosis, a virus is detected directly via detection of its proteins or nucleic acids, or 
indirectly via an immunological response to the virus. Generally, each method presents a 
different set of pros and cons with respect to sensitivity, efficiency and feasibility. Depending on 
the circumstances at which the viral sample was collected, virus type and concentration, certain 
methods may be more effective than others. As such, timely, accurate and sensitive detection of 
viruses is still difficult today.  
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 One widely-used method is to “grow” the virus in cell cultures [15]. When the virus 
infects a host cell, the host cell may undergo changes such as cell rounding, disorientation, 
swelling, shrinking, or death. These cytopathic effects may be a defense mechanism used by the 
host cell against the virus or induced by the virus to enhance its survivability and reproduction. 
Since different viruses produce different cytopathic effects on different cells, the identity of the 
virus may be deduced from the cytopathic effects observed. Although large concentrations of 
viral products can be obtained in a successful culture, the process is labour-intensive and may 
potentially take up to 4 weeks to complete. Contamination is always a risk and sensitivity is 
often poor as it depends largely on the compatibility between the live virus and the cell lines 
chosen. Furthermore, a number of viruses such as hepatitis B, parvovirus and papillomavirus will 
not grow in cell cultures.  
 Another widely-used approach to detect viruses is to detect the presence of antigens or 
antibodies in bodily fluids. Such antibodies are typically produced in response to an infection 
and can be detected using techniques such as direct or immune fluorescence assays or enzyme 
immuno assays (ELISA). However, the effectiveness varies with different viruses. For example, 
ELISA has proven to be a highly sensitive test for HIV [16]. On the other hand, such an 
approach would not be useful in the diagnosis of certain viruses such as respiratory viruses, 
enteroviruses and diarrhoeal viruses because antibodies are produced only after the onset of 
clinical disease [17].  
A direct method to detect viruses is to view them using electron microscopes. This 
method requires a purified or high concentration of virus that can be obtained directly from 
clinical sample. An experienced technician then discerns the virus by its physical structure 
features. Viruses such as poxviruses and herpesviruses can be easily identified using this 
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technology [18]. The high cost in equipment and maintenance and low sensitivity are the major 
drawbacks of this method.  
 In recent years, molecular methods based on the detection of the viral genome have been 
touted as the future direction of viral diagnosis [19]. One of the most commonly used methods 
for virus detection is polymerase chain reaction (PCR) [20]. PCR is used to amplify a single or 
few copies of the target nucleic sequence many folds using synthetic oligonucleotides flanking 
the target nucleic sequence, generating thousands to millions of copies of the target sequence. 
Detection of sequence product of the PCR assay may be achieved by gel electrophoresis. 
Although PCR is highly sensitive (may detect down to one viral genome per sample volume) and 
fast, the selection of suitably specific oligonucleotides (primers) that flank the target nucleic 
sequence may be difficult. Furthermore, sequence information of the suspected viruses must also 
be known in order to select the primers for amplification. Consequently, PCR cannot be used to 
detect novel viruses. A promising technology that has began to establish itself as an important 
diagnostic tool is the microarray or DNA chip [21]. A microarray consists of thousands, even 
millions, of fluorescence-labeled nucleic acid probes that bind (hybridize) with high specificity 
to complementary sequences of nucleic acid. By analyzing the microarray data, the virus present 
in the sample is easily identified since only probes that are complementary to the sequences of 
the virus will show high levels of fluorescence. Using microarrays, it is now possible to detect a 
large number of viruses at one time by designing and including specific probes complementary 
to sequences of all viruses of interest. Thus, compared to traditional methods, microarrays are far 
less reliant on clinical prediction of the infectious source for diagnosis [22]. Unfortunately, 
microarrays are susceptible to non-specific hybridization noise and its sensitivity is usually not 
higher than traditional detection methods such as cell cultures, antibody-based detection and 
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PCR. In order to make microarrays a sensitive and reliable viral detection tool, there is much 
interest in developing new sample preparation and hybridization protocols, as well as analysis 
methods to overcome the shortcomings of microarrays. 
 
1.3 Resequencing of Viruses 
Sequencing of viral genomes is historically performed using standard dye termination 
technologies. In dye-terminator (capillary) sequencing, negatively-charged DNA fragments are 
labeled with fluorescent dyes and applied with a high voltage to make them move through 
capillaries filled with polymer toward a positively-charged electrode in the sequencing machine. 
A laser beam is then shone on the DNA fragments just before they reach the positive electrode. 
The laser beam causes the dyes on the fragments to fluoresce. These fluorescence signals are 
detected by an optical device and converted to digital data. Since each dye emits light at different 
wavelengths, the four different bases (A, C, G, T) can be detected and distinguished [23]. 
Although capillary sequencing produces highly accurate base calls, it is slow and costly. The first 
15-40 bases and 700-900 bases thereafter of the sequences generated tend to be poor quality.  
 The drawbacks of traditional capillary sequencing have motivated the development of 
high-throughput sequencing technologies that are capable of producing millions of sequences by 
parallelization of the sequencing process [24]. This dramatically lowers the cost of DNA 
sequencing with respect to the amount of throughput, prompting many researchers to utilize 
high-throughput sequencing technologies such as 454 sequencing [25], sequencing by 
oligonucleotide ligation and detection (SOLiD) [26], and Solexa sequencing [27] for a variety of 
genome projects. High-throughput sequencing technologies are best suited to provide deep 
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sequencing data of a few samples. In our experience with the 454 system, much of the amplified 
material is still human (as the bulk of the patient sample material is human RNA with very little 
influenza RNA), requiring very deep sequencing to obtain a complete flu genome sequence, with 
one compartment of a run not yielding sufficient viral information. Furthermore, assembly of the 
sequence fragments is required before any analysis can be done. Any abnormalities or gaps in the 
assembly would then require additional runs of 454, incurring more cost and time. Hence, they 
may be ill-suited for use in viral outbreaks, where the impetus is to obtain complete genome 
sequences from as many infected individuals as possible to monitor them for potential mutations 
or recombinations that might affect drug resistance or virulence. 
 Contrary to the above mentioned sequencing technologies, sequencing by hybridization is 
a novel non-enzymatic method in which a solution of target DNA sequence is fluorescently 
labeled and hybridized to a microarray containing short known sequences (probes) [28]. A 
combinatorial method is then used to reconstruct the DNA sequence from probes with strong 
hybridization signals that bind to the target sequence [29]. Since the introduction of sequencing 
by hybridization in the late 1980s, continual research and advancement over the years have 
alleviated some of the limitations of resequencing arrays, such as cost, accuracy and high-
throughput processing. Currently, a single multiplexed resequencing array is capable of 
generating viral genomic sequences from multiple infected individuals. This translates to 
dramatic savings in cost, labour and time taken to continually obtain relatively high quality viral 
genomic sequences from infected individuals needed for evolutionary surveillance and studies in 
viral outbreaks. One major concern of using microarrays for resequencing is their susceptibility 
to non-specific hybridizations that may result in inaccurate sequence calls. As such, more 
research is needed to develop methods to analyze microarray data that may be noisy, so as to 
 8
achieve accuracies comparable to the “gold standard” traditional capillary sequencing 
techniques.  
 
1.4 Recombination Detection in Viruses 
Recombination is an important evolutionary mechanism for the continual survival of viruses. In 
addition to the ability to change its own genetic material rapidly via mutation, recombination 
allows viruses to add the capacity to exchange genetic material with one another, and to acquire 
genes from their hosts. Such capability enables viruses to (1) remove deleterious genes from 
their genomes and (2) create and spread advantages traits in an efficient manner [30]. A number 
of studies have shown that viruses do benefit from the effects of recombination. For example, a 
study on Sindbis viruses demonstrated that weaker strains of certain viruses can recombine to 
form stronger, more infectious strains [31]. Some viruses such as the bovine viral diarrhoea virus 
can also generate new variations by borrowing genetic material from their hosts [32]. Viruses 
with high recombination rates are a serious threat to human health. Antiviral drugs or vaccines 
for some viruses, such as influenza viruses, that target certain proteins have to be updated every 
few years to ensure they do not become less effective or even obsolete once these viruses 
undergo mutation or recombination [33]. For some viruses with very high evolutionary rates 
such as HIV, drugs or vaccines development have proven to be extremely difficult and may even 
be impossible without significant breakthrough in understanding virus evolution mechanisms 
[34]. 
  The identification of the locations of the recombination events is the first step to an 
accurate phylogenetic analysis, which gives us important clues on the origins, pathogenicity and 
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treatments of viruses. This led to the development of numerous sequence analysis methods and 
phylogenetic techniques that have proven to be effective and accurate for detecting and 
characterizing recombination events among viruses. Traditionally, an accurate and reliable 
multiple sequence alignment of a given set of sequences is an essential starting point for many 
tools that analyze evolution, including phylogenetics and recombination detection [35]. The 
primary focus of a multiple sequence alignment is to identify, within several related sequences, 
regions that are highly conserved in identity or similarity, and therefore probably have functional 
and/or structural significance. Conversely, sequences that share a common ancestor but have 
since diverged may have clusters of mismatches and gaps that indicate the time since they 
diverged from one another. As such, a multiple sequence alignment of the query sequences is the 
de facto input for recombination detection tools.  
The main goal of recombination detection tools is to find recombination breakpoints, the 
exact locations where a recombination event occurs in a sequence. Generally, the detection of 
breakpoints depends on the strength of a recombination event, which is affected by factors such 
as the mutation rate and the time at which the recombination event took place [36]. The 
unpredictable conditions at which recombination events occur make the task of finding 
breakpoints difficult. For recombination events which make little changes to the sequence, the 
detection of breakpoints may even be impossible [37]. Thus, in order to pinpoint the precise 
locations where recombination events may have taken place, regardless of when they happened 
or frequency, and to test their correctness, it is vital to develop sensitive and accurate methods 
for detecting recombination. 
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1.5 Literature Survey 
1.5.1 Diagnostic and Detection of Viruses 
DNA microarrays have become an essential tool in clinical diagnostics. In recent years, 
microarrays have been used to detect and subtype a multitude of human viruses such as 
herpesviruses [38], respiratory viruses [39], human rotaviruses [40], papillomaviruses [41], 
orthopoxviruses [42], hepatitis [43], cytomegalovirus [44], and the influenza virus [45, 46]. 
Comprehensive pan-viral detection microarrays have also aided in the discovery of novel viruses 
[46, 47].  
Though virus detection by microarray is a young field, a number of different platforms 
and approaches have been described, each with important attributes. For example, the array 
described by Wang et. al. [46] is based on probes designed to recognize the most conserved viral 
domains, facilitating the detection of a taxonomic fingerprint that provides powerful clues to 
viral identity with minimal probe usage. Lin et. al. [39], on the other hand, described a probe-
dense resequencing array capable of detecting a smaller set of predefined pathogens, but with 
higher detection specificity, including the ability to discern highly related subtypes. Thus, it is 
important to devise a probe design strategy that allows us to detect viruses in accordance to the 
intended use of the detection array. 
The accuracy of virus detection depends largely on the algorithms used to analyze 
microarray data. Simple algorithms usually determine whether a particular virus is present or not 
depending on the relative abundance of probes with high hybridization intensities [45, 47, 48]. 
The pathogen predictions made by these simple algorithms may be affected by systematic and 
cross-hybridization errors frequently experienced by microarrays. Unfortunately, few other 
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algorithms exist. One such algorithm that has been reported and validated, E-predict [46], 
matches hybridization signatures with predicted pathogen signatures derived from the theoretical 
free energy of hybridization for each microarray probe. E-predict is less geared towards 
identifying and distinguishing specific pathogen strains, and aimed more at elucidating the best 
possible candidates as supported by the available probes. As such, this approach is particularly 
advantageous in situations where the sequence of the virus is not fully known. Another approach 
[49] uses tiling resequencing microarrays to obtain sequence fragments from consecutive (≥ 3) 
high confidence base calls. BLAST is then used to match these sequence fragments to a public 
database of viruses for diagnosis. However, due to the high number of probes required for tiling 
the viral genomes, this approach can only detect a limited number of viruses. 
 
1.5.2 Resequencing of Viruses 
Resequencing microarrays offer a low-cost, efficient and high-throughput solution to obtain 
whole-genome primary sequences of viruses for practical large-scale bio-surveillance and 
epidemiology studies. For example, resequencing microarrays have been used to generate 
complete sequences of the severe acute respiratory syndrome (SARS) coronavirus [50, 51] and 
poxviruses [52]. Recently, resequencing microarrays have also been used successfully to 
generate primary sequences for highly dangerous biothreat agents such as filoviruses of the 
Ebola Zaire group, or the Machupo and Lassa arenaviruses [53]. 
 Base-calling is a critical step in analyzing resequencing microarrays. There are two main 
base-calling software commonly used in the reported studies, namely the ABACUS algorithm 
[54] and Nimblescan PBC algorithm [50]. Both algorithms employ a gain-of-signal approach 
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[55] based on relative hybridization to allele-specific probes complementary to each of the four 
possible nucleotides at interrogated nucleotide position for base-calling. A probability based on 
the degree of differentiation of hybridization intensities among the querying probes is then 
computed for each base call. A base call is of high confidence if they exceed a pre-defined 
significance or probability threshold. This approach is statistically sound but is susceptible to a 
myriad of factors such as mutations, random noise, probe quality, sample quality and 
experimental conditions. These artifacts can cause poor hybridization performance, resulting in 
ambiguous and sometimes false-positive calls. 
 Efforts have been made to improve the call rates and accuracies of existing base-calling 
algorithms. For example, Zhan and Kulp used sequences of the probe and target to predict probe 
intensities in resequencing microarrays [56]. By accounting for probes may be noisy, they were 
able to achieve a higher call rate and accuracy than ABACUS. Another approach proposed by 
Pandya et al. involves a post-processing strategy to filter low confidence base calls made by 
ABACUS that reside in problematic regions such as highly mutative and repeat regions [57]. 
Although the number of false positive base calls was reduced, the call rate may suffer if too 
stringent filters are used. Most recently, Zheng et al. identified “dips” in hybridization intensities 
of probes near/at mutation sites of variant samples when compared against non-variant control 
samples [58]. As such, they were able to identify variations in the sequence more accurately.  
 
1.5.3 Recombination Detection in Viruses 
Over the years, a wide range of tools to detect recombination have been developed using many 
different strategies. Most of these tools adopted strategies that detected changes in phylogeny or 
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distance metrics at different parts of the input sequences as an indication of the presence of 
recombination. There are also tools that use probabilistic methods, substitution models or cost 
models to infer recombination. Comparative studies on the performances of different 
recombination detection methods have also been carried out [59, 60]. Regardless of the strategies 
they used, recombination detection tools employ (as an initial step) a multiple sequence 
alignment of all input sequences. A multiple sequence alignment tries to align all sequences in a 
given query set. If two sequences in an alignment are descendents of a common ancestor, 
mismatches can be interpreted as point mutations and gaps as insertions/deletions introduced in 
one or both lineages in the time since they diverged from one another. The absence of 
substitutions, or the presence of only very conservative substitutions in a particular region of the 
sequence, suggest that this region is structural or functional importance. Multiple alignments are 
often used in identifying conserved sequence regions across a group of sequences hypothesized 
to be evolutionarily related. 
 We focus on a particular class of methods which uses a sliding window to detect 
recombination. Sliding window approaches are preferred over those that use a global reference 
tree because they can localize breakpoints more accurately and thus detect weak recombination 
events in the presence of strong recombination events [61]. Typically, recombination is detected 
by comparing and noting significant differences in distance measures (distance-based) or in 
phylogenetic trees’ topologies (phylogeny-based) computed for the alignments in adjacent 
windows. 
 Distance-based window methods such as PhyPro [36] and DSS [62] are fast and fairly 
accurate. PhyPro computes, for every sliding window, a test statistic known as the minimum 
distance vector correlation using only non-conserved sites of an alignment. Then, they estimated 
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the p-value for the null hypothesis of no recombination by permuting the alignment 1000 times 
and counting the number of times the original minimum distance vector correlation was smaller 
than the minimum distance vector correlation for each permutation. In DSS, a length-500 
window is slid along an alignment of DNA sequences. For each window, two distance matrices 
(one for each half of the window) are calculated according to some Markov model of nucleotide 
substitution. A sum-of-squares statistic is then computed for each distance matrix. Since each 
distance matrix encodes the phylogenetic relationships in its corresponding window, the presence 
of recombination will result in a big difference in the two sum-of-squares statistics for the two 
matrices. Unfortunately, distance-based methods tend to suffer from information loss when 
estimating recombination. Phylogenetic information is lost when only pair-wise distance 
comparisons are made using conventional distance metrics that measures only the global 
homology between two sequences. 
On the other hand, phylogeny-based window methods such as PDM [63], Pruned-PDM 
[64] and RECOMP [65] try to generate the most likely phylogenetic trees for the alignments 
enclosed in neighboring windows and compare them to estimate recombination more accurately. 
The PDM and Pruned-PDM methods focused on estimating the topology changes based on a 
likelihood score. To reduce the uncertainty of tree estimation from short sequence alignments 
enclosed by the sliding window, they used a distribution of trees instead of a single tree as 
reference. Although accurate, their methods are very slow due to the need for Markov chain 
Monte Carlo simulations and hence intractable for larger datasets. RECOMP was then developed 
to provide a faster means of detecting recombination. Using a sliding window, a set of trees is 
generated for each window based on a maximum parsimony heuristic. Recombination is 
determined by comparing four different measures such as the Robinson-Foulds distance [66] of 
 15
sets of trees in adjacent windows. An accuracy comparable to Pruned-PDM is claimed but the 
interpretation of the four measures as an indication of recombination is sometimes not straight-
forward and may even be ambiguous at times. 
Regardless of distance-based or phylogeny-based methods, a sliding window approach 
has a major concern: the selection of window length. In previous works, the window length is 
usually arbitrary chosen within the range of 200–500. However, window length affects the 
sensitivity and accuracy of window-based methods to detect recombination. Recent works have 
shown that their results are most accurate when the given window length is approximately the 
recombinant subsequence length [62, 64]. If the length of the recombinant is not known in 
advance, an algorithm using different window lengths may produce vastly different analysis 
results on the same dataset. Furthermore, there may be problems in detecting recombinant 
regions shorter than the given window length due to the noise caused by the original sequence on 
either side of the recombinant subsequence included in the window. 
Recently, a method to detect recombination without the use of sliding windows was 
introduced. Recco [67] uses a model of cost minimization and dynamic programming to detect 
recombination breakpoints. The basic model is to construct each sequence in the alignment in 
turn, from the other sequences in the alignment using only the mutation and recombination 
operators such as insertion and deletion. The minimum cost solution identifies the best 
recombination breakpoints and also the parental sequences. The performance of Recco is 
enhanced by a succeeding sensitivity analysis that provides an intuitive visualization of the 
solution. A major limitation of this method is that a recombinant sequence may not be detected if 
there is another similar sequence in the alignment. Consequently, the user needs to manually 
remove the closest sequence to the putative recombinant sequence iteratively. 
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1.6 Overview of Thesis 
The rest of the thesis contains details on the detection and resequencing of viruses, and how their 
genomes are analyzed. Through the use of microarray technology, we are able to detect and 
resequence viruses in a cost-effective, efficient and high-throughput manner. However, more 
research is required to address accuracy and sensitivity issues faced by existing microarray data 
analysis methods. Downstream interpretation of sequence information also poses interesting 
challenges. An accurate interpretation may provide valuable insights on viral evolution and aid 
the development of viral treatments and vaccines. 
In Chapter 2, we describe how PCR techniques are used to amplify DNA fragments of a 
virus to a magnitude required for a successful microarray hybridization. We also present the 
difficulties and limitations of various PCR amplification techniques on viruses. The main novel 
contribution of this chapter is a way to predict how well a random primer can amplify a given set 
of viruses. We then describe a fast algorithm to design better primers for amplification, along 
with wet-lab validation results. Implications of amplification efficiency on microarray probe 
selection and quality of data are also discussed. 
In Chapter 3, we describe how microarrays are used to detect viruses and study the 
factors that affect detection accuracy. We report the results of a systematic investigation of the 
complex relationships between viral amplification efficiency, hybridization signal output, target-
probe annealing specificity, and reproducibility of viral detection using a custom designed 
microarray platform. The novel contributions are a methodology for the in silico prediction of 
viral “signatures” and a statistics-based virus detection algorithm that can identify sequence-
characterized and co-infecting viruses with low false positive rate. 
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In Chapter 4, we explore the capabilities of microarrays to generate whole-genome 
primary sequences of viruses for large-scale evolutionary biosurveillance. In response to the 
most recent H1N1 pandemic, we developed a resequencing kit that is capable of interrogating all 
eight segments of the H1N1 2009 influenza A virus genome and its variants. The novel 
contribution is a base-calling software (EvolSTAR) that introduces new methods that utilizes 
neighbourhood hybridization intensity profiles and substitution bias of probes on the microarray 
for mutation confirmation and recovery of ambiguous base queries. We demonstrate that 
EvolSTAR is highly accurate and has high call rates with a pilot study of 15 patient samples. 
In Chapter 5, we describe various techniques to detect recombination events from 
genomic sequences of viruses. Recombination detection is important for a better understanding 
of viral evolution, more accurate genotyping and advancements in drug and vaccine 
developments. The main contribution of this chapter is a fast and accurate distance-based sliding-
window method to detect recombination in a multiple sequence alignment. Using synthetic and 
biological datasets, we show that our method is more accurate than existing phylogeny-based 
methods. We also discuss how our method has potential use in other related applications such as 
genotyping. 
 In Chapter 6, we discuss the practical implications of this thesis in the field of 
evolutionary research and clinical decision making. We then present and summarize the main 






This thesis is based on the following published material: 
• Wong CW, Lee WH, Leong WY, Soh SW, Kartasasmita CB, Simoes EA, Hibberd ML, 
Sung WK, Miller LD. Optimization and clinical validation of a pathogen detection 
microarray. Genome Biol., 2007, 8(5): R93. 
• Lee WH, WK Sung. RB-Finder: An Improved Distance-based Sliding Window Method 
to Detect Recombination Breakpoints. In RECOMB, 2007. 
• Lee WH, Sung WK. RB-finder: an improved distance-based sliding window method to 
detect recombination breakpoints. J Comput Biol., 2008, 15(7): 881-98. 
• Lee WH, Wong CW, Leong WY, Miller LD, Sung WK. LOMA: a fast method to 
generate efficient tagged-random primers despite amplification bias of random PCR on 
pathogens. BMC Bioinformatics, 2008, 9: 368. 
• Lee WH, Koh CW, Chan YS, Aw PPK, Loh KH, Han BL, Thien PL, Nai GYW, ML 
Hibberd, CW Wong, WK Sung. Large Scale Evolutionary Surveillance of the 2009 
H1N1 Influenza A Virus Using Resequencing Arrays. Nucleic Acids Research, 2010. 
• Lee VJ, Yap J, Cook AR, Chen MI, Tay J, Tan BH, Loh JP, Chew SW, Koh WH, Lin R, 
Cui L, Lee WH, Sung WK, Wong CW, Hibberd ML, Kang WL, Seet B, Tambyah PA. 
Oseltamivir ring prophylaxis for containment of Influenza A (H1N1-2009) outbreaks. 
New England Journal of Medicine, 2010. 
 19
Chapter 2 
AMPLIFICATION OF VIRAL GENOMES 
2.1 Polymerase Chain Reaction and its Limitations on Viral 
Genome Amplification 
The Polymerase Chain Reaction (PCR) is a laboratory technique that “amplifies” a particular 
DNA sequence, generating millions of copies of it in the process. PCR uses specifically designed 
primers that are complementary to the sequence to be amplified. The primers provide a starting 
point for the extension of the DNA by a DNA polymerase (usually Taq or Pfu polymerase). 
Amplification is carried out in cycles. First, the DNA sample is heated up to separate the double 
strands. The sample is cooled slowly, allowing the primers to bind. Then, the sample is incubated 
at 72°C so that the DNA polymerase can extend the primers, creating a long complementary 
strand of DNA. As PCR progresses, the DNA generated is itself used as a template for 
replication, setting in motion a chain reaction in which the DNA template is exponentially 
amplified [68]. Furthermore, PCR requires only a minute amount of DNA sample for 
amplification. This extremely high efficiency and sensitivity has made PCR an essential tool for 
many applications such as forensic analysis [69], genome sequencing [70] and cancer diagnostics 
[71].  
Another important application of PCR is the amplification and subsequent detection and 
identification of viruses for disease diagnosis [72, 73]. PCR-based virus detection is highly 
sensitive and accurate, with the capability to detect viruses soon after infection and even before 
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the onset of disease. In practice, there are several factors that may cause PCR-based detection to 
fail. PCR needs to use primers that are specific to the targeted sequence for a successfully 
amplification. These primers are typically designed from sequence information stored in public 
databases. However, as some viruses mutate or recombine, their sequence information may 
become inaccurate. Moreover, sequence information for novel viruses such as severe acute 
respiratory syndrome (SARS) and H1N1 2009 influenza virus will not be available until much 
later. Even if the virus is not novel, a clinical prediction of the infectious source would have to be 
made before PCR can be conducted [22]. 
 
2.2 Tagged-random Primer Amplification 
The limitations of PCR in amplifying novel, unknown or highly mutative viruses have led to the 
development of an alternative amplification strategy known as tagged-random primer 
amplification (T-PCR). Unlike PCR which requires the use of specific primers chosen from 
target sequences, T-PCR uses a tagged-random primer consisting of a constant 17 bp at the 5’-
end known as the 5’ tag and a random oligomer (unknown base N) of length 9-15 at the 3’-end 
which could theoretically bind to any DNA sequence [74]. However, many viruses, such as 
influenza viruses and retroviruses, are composed of RNA rather than DNA. As a result, tagged-
random primers cannot be used directly to amplify such viruses. To amplify RNA viruses, a 
variant of PCR known as reverse transcription polymerase chain reaction (RT-PCR) is needed. In 
RT-PCR, RNA is first reverse transcribed into cDNA using the enzyme reverse transcriptase. In 
theory, the random oligomer now binds indiscriminately to the nucleic acids template. The 
resulting cDNA is then amplified using the 17-mer 5’ tag to generate PCR products (Figure 1). 
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Figure 1: RT-PCR binding process of tagged-random primers on a RNA viral sequence followed by 
PCR. 
 
In practice, T-PCR does not guarantee the genome-wide amplification of the virus in the 
sample. The exact locations where the random primers bind could be influenced by the presence 
of intra-primer secondary structure formation (ie the 5’-end tag forms a dimer or hairpin with the 
3’-end random oligomer) or melting temperatures [75]. This differential binding of the tagged-
random primers to different parts of the viral genome creates an amplification bias that prevents 
certain regions from being amplified, resulting in incomplete amplification of the target virus. 
Several studies involving microarray experiments using T-PCR that have reported the lack of 
hybridization signals in tiling probes that reside in certain regions of the viruses in their samples, 




2.3 Amplification Efficiency Model of the RT-PCR Process 
The binding affinity of a primer pair to the target genome impacts RT-PCR efficiency. In the 
case of using tagged-random primers, the quality of the RT-PCR product depends on how well a 
tagged-random primer instantiation pair binds to the target genome. Here, we termed a particular 
configuration of the given tagged-random primer as a tagged-random primer instance. For 
example, (5’-GTT TCC CAG TCA CGA TA TTTTAAAAG-3’) and (5’-GTT TCC CAG TCA 
CGA TA CATCATCAT-3’) are instantiations of the tagged-random primer (5’-GTT TCC CAG 
TCA CGA TA NNNNNNNNN-3’). Some instantiations of the tagged-random primer can bind 
better to the target genome than others. The identification of such tagged-random primer 
instantiations and where they bind to the target genome gives us an indication of how likely a 
particular region of the target genome will be amplified. Using this approach, we proposed an 
amplification efficiency model which computes an Amplification Efficiency Score (AES) for 
every position of a target genome.  
As a concrete example for our modeling, we use a tagged-random primer that has a fixed 
17-mer header and a variable 9-mer tail of the form (5’-GTT TCC CAG TCA CGA TAN NNN 
NNN NN-3’). This tagged-random primer is commonly used in virus detection experiments [78, 
79, 80]. Let va be the actual virus in the sample. To get a RT-PCR product in a region between 
positions i and j of va, we require (1) a forward primer binding to position i, (2) a reverse primer 
binding to position j and (3) λl ≤ |i – j| ≤ λu where λl and λu are the lower and upper bounds of the 
desired PCR product length respectively (Figure 2). 
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Figure 2: Amplification efficiency model of the RT-PCR binding process of an instantiation of a tagged-
random primer on a RNA virus va. 
 
Consider a pair of forward and reverse tagged-random primer instantiations where the 
forward primer is at a particular position i of va, the reverse primer is at position j of va and |i – j| 
is the product length. Let Pf(i) and Pr(j) be the probability that the forward primer can bind to 
position i and the probability that the reverse primer can bind to position j respectively. For 
simplicity, we assume that a random (forward or reverse) primer instantiation can bind to a 
particular position i of va only if 9-mer of the instantiated nonamers of the random primer is a 
reverse complement of the length-9 substring at position i of va (Note that other binding criteria 
such as 75% similarity rule or nearest-neighbour binding free energy [81] can be used as well). 
Thus, all other instantiations of the given tagged-random primer whose instantiated nonamers is 
not a subsequence of va, do not contribute to the amplification process and thus omitted from the 
computation of AES. We compute Pf(i) and Pr(j) based on well-established primer design criteria 
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[82]. The idea is that Pf(i) and Pr(j) will be small if the forward primer or reverse primer forms 
self-dimers or has extreme melting temperatures, or form a significant primer-dimer with each 
other. Another consideration is that if the fixed 17 basepairs 5-end tag of the given random 
primer is similar to va, it may lead to mispriming and thus results in a lower Pf(i) and Pr(j) for all 
i and j. 
It is difficult to assess the exact extent of influence of primer-dimers and melting 
temperatures on amplification. Hence, we estimate Pf(i) and Pr(j) using a simple model: 
1. A primer cannot bind to the sequence efficiently if it folds onto itself. A primer is a self-
dimer if it forms a 3’-end or internal hairpin with three or more bases. Thus, Pf(i) = 0 if 
the forward primer at i forms a self-dimer. Similarly, Pr(j) = 0 if the reverse primer at j 
forms a self-dimer. 
2. The RT-PCR process is performed at a certain temperature, normally 55 oC to 60oC. If the 
melting temperature of a primer is not at this ideal temperature, then the primer may not 
bind to the sequence. Hence, we model this observation by decreasing Pf(i) and Pr(j) 
proportionally to the difference in the melting temperature of the forward primer and 
reverse primer to the ideal experimental temperature respectively. Specifically, Pf(i) = 1 – 
(|Tm(forward primer) – TM|/TM) and Pr(j) = 1 – (|Tm(reverse primer) – TM|/TM) where 
TM is the ideal experimental temperature and Tm(x) is the melting temperature of a 
primer x. We compute Tm(x) = 81.5 + 16.6 (log M) + 0.41 (% G+C) - 0.72 (% 
formamide) where M is the monovalent salt molarity, and (% G+C) the percentage of 
guanine plus cytosine residues in DNA [83]. 
3. To avoid mispriming, if the 17bp fixed tag of the tagged-random primer has more than 
75% similarity to any subsequence of the target genome, we discard this random primer. 
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That is, Pf(i) = 0 if the forward primer at i has a fixed tag with more than 75% similarity 
to any subsequence of the target genome. Similarly, Pr(j) = 0 if the reverse primer at j has 
a fixed tag with more than 75% similarity to any subsequence of the target genome.  
  
Based on our model, the probability that a pair of random primer instantiations give a 
good quality PCR product from position i to j on va is Pf(i) × Pr(j). Due to the abundance of 
random primer instantiations used in a RT-PCR process, it is likely that all pairs of random 
primer instantiations that can effectively bind to va will contribute a PCR product. Thus, for a 
valid forward primer at position i, we must compute the above probabilities for a range of 
positions j at which a valid reverse primer exists, ie λl ≤ |i – j| ≤ λu. Thus, an Amplification 
Efficiency Score, AESx, for every position x of va can be computed by considering the combined 
effect of all forward and reverse primer-pairs that amplifies it:  
max( 1, )
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Once we compute the AES for all positions of va, we plot the AES against the genomic positions 
of va. This generates a graph which indicates the regions in va predicted to be amplified 
efficiently by the given tagged-random primer (represented by peaks) and regions that do not 
(represented by troughs). To validate the algorithm, we conducted two parallel experiments using 
two microarrays, each consisting of 1948 probes tiled across the RSV B genome. Two 
biologically identical samples of RSV B are amplified using two different tagged-random 
primers:  
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1. Primer A1 (5'-GTT TCC CAG TCA CGA TA NNNNNNNNN-3'): A commercially 
available tagged-random primer. 
2. Primer A2 (5'-GAT GAG GGA AGA TGG GG NNNNNNNNN-3'): Primer with 
highest AES among 10000 randomly generated tags. 
Next, we ranked the hybridization signal intensities for all 1,948 probes tiled across the RSV B 
genome in each microarray experiment and compared them to the AES values of the tagged-
random primer used for amplification (Figure 3). We observed that high AES significantly 
correlates to probe hybridization signal intensity above the detection threshold (P=2.2x10-16; 
Fisher’s Exact Test). In another set of experiments involving a patient sample positive for 
metapneumovirus (hMPV), the probes tiled across the hMPV genome showed a similar result, 
P=1.3x10-9. Repeatedly, we observed that higher AES correlated with greater probe detection, 
with, on average, >70% detection for probes in the top 20% AES. 
Our model allows us to predict how successful the amplification on a target viral genome 
will be given a particular tagged-random primer. An ideal tagged-random primer would generate 
high AES values uniformly across the whole target genome. This quantification of the efficiency 
of amplification of a tagged-random primer on a target genome in the form of AES also enables 
us to compare the effectiveness of different tagged-random primers if they are to be used to 
amplify the genome. For example, tagged-random primer r1 is predicted to work better than 
tagged-random primer r2 if the average AES of r1 across a target genome is higher than that of r2. 
An important application of our AES model is in the design of probes for a virus-detection 
microarray. Probes should be chosen in regions in the target viral genomes that can be amplified 
efficiently by the tagged-random primer used. Conversely, we should omit probes from regions 
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in the target genomes
 
which are predicted not to amplify efficiently since we cannot tell if these 
probes did not hybridize due to the absence of the target viruses
 
in the sample or just that the 
amplification by the random primers failed. 
 
 
Figure 3: Correlation of probe hybridization signals with AES of tagged-random primers A1 and A2 in a 
RSV B sample. 
 
2.4 Generating the Tag of a Tagged-Random Primer using LOMA 
Amplification failure may occur if there are many regions of the target genome where the 
tagged-random primer cannot bind. As such, using any available commercial tagged-random 
primer or a tagged-random primer that was used in other publications may not guarantee a 
successful amplification on a target genome. Although the computation of AES allowed us to 
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compare the amplification efficiency of different tagged-random primers on a target genome, it 
would be most useful if we know the tagged-random primer that binds to the given genome 
optimally. 
The best way to obtain the most efficient tagged-random primer to amplify a target 
genome is to compute the AES graph for all possible combinations of the 17-bp 5'end tag and 
choose the tag that has the highest average AES with the target genome. This is impractical as 
this would require 417 runs of the AES computation algorithm. A naïve approach would be to 
randomly generate a large number of tags (eg. 10000) and choose the one that has the highest 
average AES with the target genome. Other similar randomization approaches could also be used 
to improve the chances of getting a more efficient tag to amplify the target genome. However, 
these approaches are still slow especially when we need to choose an efficient tagged-random 
primer for multiple genomes. 
We propose LOMA (Least Occurrence Merging Algorithm), a more deterministic and 
faster algorithm to generate an efficient tag for a target genome va. The idea is to use a "divide 
and conquer" strategy to generate n-bp tags by concatenating m shorter k-mers where m = n/k. 
Recall that the 5'end tag of the tagged-random primer should be not similar to va to avoid 
mispriming. To form such a tag, the constituent k-mers should also be dissimilar to va. Based on 
this criterion, we compute the number of occurrences with more than 75% similarity in va for 
each of the 4k k-mers. Then, we sort the k-mers based on their occurrence count in va in 
ascending order. Tags are generated using the top ranking k-mers whose number of occurrences 
in va is lower than some threshold T. Ideally, we want to generate tags using only k-mers with no 
occurrence in va, ie T = 0. 
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Figure 4: Flowchart of LOMA with n = 17, k = 9 and T = 0. 
 
Suppose x k-mers have occurrences in va less than T. We generate a tag by concatenating 
any m of the x k-mers. This results in xm possible tags. Since x is small and m is typically 2 or 3, 
the total number of tags generated is much less compared to a brute force or randomized 
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approach. Furthermore, the xm tags generated by our method are guaranteed to be dissimilar to va. 
Thus, all there is left to do is to compute the AES with va of each of the xm tags and choose the 
one with the highest average AES across va. Figure 4 shows the flowchart of our algorithm. 
Unlike randomized approaches, LOMA is easily extended to generate an efficient tag for 
multiple genomes. Specifically, given a set of genomes V, we need only to modify step one of 
the algorithm to compute the number of occurrences with more than 75% similarity in every 
genome in V for each of the 4k k-mers. Once candidate random-tags are generated, we compute 
their AES with each of the genomes in V and choose the one with the highest average AES for 
all the genomes in V. 
 
2.5 Experimental Evaluation of LOMA 
We describe experiments to test the hypothesis that different tagged-random primers have 
different amplification efficiencies and to assess the effectiveness of our algorithm to generate a 
good tagged-random primer. In our experiments, we use eight human nasopharyngeal aspirate 
patient samples obtained from children under 4 years of age with lower respiratory tract 
infections. Using real-time PCR with specific primers, we confirmed that five samples contain 
human respiratory syncytial virus (RSV) while the remaining three samples contain human 
metapneumovirus (HMPV). 
Three tagged-random primers are then used to amplify the eight samples: 
1. Primer A1 (5'-GTT TCC CAG TCA CGA TA NNNNNNNNN-3'): A commercially 
available tagged-random primer. 
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2. Primer A2 (5'-GAT GAG GGA AGA TGG GG NNNNNNNNN-3'): Primer with 
highest AES among 10000 randomly generated tags. 
3. Primer A3 (5'-TAG GTC GGT CGG TAG GT NNNNNNNNN-3'): Primer generated 
using our proposed algorithm LOMA. 
Subsequently, the samples are hybridized onto our virus detection chip. Since our virus 
detection chip contains tiling 40-mer probes of both RSV and HMPV, the number and 
distribution of the probes with high signal intensities would give a good indication of the amount 
of PCR products generated across the target genome by a tagged-random primer. We expect that 
a tagged-random primer with desirable amplification efficiency that generates sufficient PCR 
products uniformly across the whole target genome would result in high signal intensity probes 
distributed evenly across the whole genome. 
We present the first set of experiments involving the amplification of five RSV patient 
samples by the three tagged-random primers A1, A2 and A3. In each experiment involving a 
particular pair of RSV patient sample and random-tagged primer, hybridization signal intensities 
for the 1948 probes tiled across the 15225 bp RSV genome were compared to their 
corresponding AES along the genome. When using primer A1, we obtained AES with values less 
than 5000 with an average of 3300. However, when primers A2 and A3 are used, the AES 
averages are 110000 and 140000, respectively. This dramatic increase in predicted amplification 
efficiency gave an indication that in theory, our designed tagged-random primers A2 and 
particularly A3 perform much better than A1. 
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Figure 5: Application of AES on a RSV sample. An RSV patient sample was amplified separately using 
primer A1, primer A2 and primer A3. Hybridization signals of probes after amplification by each primer 
are shown as a heatmap. The probes that have detectable signals above threshold are shown in 
orange/yellow in the corresponding heatmaps. The graph below the heatmaps shows our AES prediction 
for the three primers: A1 (orange line), primer A2 (pink line) and primer A3 (dark blue line). Our AES 
predictions closely matches the actual hybridization results, ie primer A3 performs slightly better than 
primer A2 but both A3 and A2 performs significantly better than A1 on RSV. 
 
Recall that probes in regions of high AES are expected to be least affected by a poor 
amplification and thus have the correct high hybridization signals if the virus is present in the 
sample. For all the experiments, we observed that high AES significantly correlates to probe 
hybridization signal intensity above the detection threshold with a p-value of 2.2 × 10-16 using 
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the Fisher's exact test. About 80% of the probes with high signal intensities (≥ mean + 3 standard 
deviation) have high AES values. We also observed that primers A2 and A3 showed a 
tremendous improvement in overall PCR efficiency in amplifying RSV over primer A1. This 
increase in PCR efficiency resulted in increased hybridization of DNA to the probes and is 
reflected in the uniformly higher signal intensities observed using primer A2 and A3. This is 
illustrated in Figure 5. Further analysis of the RSV experiments revealed that only 20% to 30% 
of the 1948 RSV probes had signal intensities above detection threshold when primer A1 was 
used. By contrast, the use of primer A2 resulted in 60% to 71% of probes with signal intensities 
above detection threshold. Primer A3 fared slightly better than primer A2, resulting in more than 
70% of the probes having signal intensities above detection threshold. 
We conducted another set of experiments to verify that the observations made involving 
RSV and the three tagged-random primers are not isolated observations and that they can be 
replicated in other genomes as well. Following the experimental procedure used in the previous 
set of experiments, three patient samples containing HMPV are subjected to amplification by 
primers A1, A2 and A3. Similarly, in each experiment involving a particular pair of HMPV 
patient sample and tagged-random primer, hybridization signal intensities for the 1705 probes 
tiled across the 13335bp HMPV genome were compared to their corresponding AES along the 
genome. Figure 6 shows the heatmaps and AES plots of the HMPV genome when amplified by 
primers A1, A2 and A3. The results are similar to that of the first set of experiments on RSV. In 
the three samples, Primer A1 performs worse on HMPV than RSV, causing only < 8% of the 
1705 probes to be detected above threshold. Primers A2 and A3 performed much better than 
primer A1, causing >80% and > 88% of the probes to be detected above threshold respectively. 
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Figure 6: Application of AES on a HMPV sample. An HMPV patient sample was amplified separately 
using primer A1, primer A2 and primer A3. Hybridization signals of probes after amplification by each 
primer are shown as a heatmap. The probes that have detectable signals above threshold are shown in 
orange/yellow in the corresponding heatmaps. The graph below the heatmaps shows our AES prediction 
for the three primers: A1 (orange line), primer A2 (pink line) and primer A3 (dark blue line). Our AES 
predictions closely matches the actual hybridization results, ie primer A3 performs slightly better than 
primer A2 but both A3 and A2 performs significantly better than A1 on HMPV. 
 
Our experiments have shown that the commonly used primer A1 amplify RSV and 
HMPV poorly. Further analysis reveals that many instances of the primer A1 that are supposed 
to bind to RSV and HMPV form self-dimers and hence unable to amplify the genome efficiently. 
On the other hand, primers A2 and A3 amplified RSV and HMPV efficiently. However, 
compared to primer A2, primer A3 was generated in a much shorter time by LOMA and 
performs just as well, if not better. 
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2.6 Multiplexing Tagged-random Primers 
LOMA generates random-tagged primers that are capable of amplifying their target genomes 
efficiently with coverage of more than 70% up to 90%. We explore the possibility of using 
multiple tagged-random primers to achieve a more complete amplification of the target genome. 
In our experiments, we observed that one tagged-random- primer may amplify a 
particular region of a target genome more efficiently than another tagged-random primer. For 
example in Figure 6 at genomic positions 1500–1900 of HMPV, the heatmap shows that primer 
A3 performs much better than primer A2. On the other hand, on the same genome at positions 
2000–2200, the heatmap shows that primer A2 performs better than primer A3. This suggests 
that it is possible to design multiple collaborating tagged-random primers to amplify a target 
genome. The idea is to design additional tagged-random primers that have regions with high 
AES covering the regions with low AES of existing random-tagged primers. This is shown in 
Figure 7. 
Although this approach is highly viable as suggested by our experimental results, 
achieving a successful multiplexing of multiple random-tagged primers in the laboratory may not 
be as straight-forward as the traditional multiplexing of specific primers [84]. Recall that a 
tagged-random primer consists of random oligomers that could theoretically bind to all possible 
sequences. Using two or more tagged-random primers simultaneously in a PCR amplification 
reaction may result in the formation of primer-dimers among all instances of the tagged-random 
primers and cause the amplification to fail. To ensure higher success of multiplexing tagged-
random primers, an alternative solution is to perform the PCR reaction with the first tagged-
random primer, then perform another PCR reaction with the second tagged-random primer and 
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so on. In other words, we multiplex n tagged-random primers by performing n PCR reactions in 
series. This will avoid the problem of primer-dimers when multiplexing tagged-random primers. 
 
Figure 7: Design of multiple random-tagged primers to amplify a target genome g. Original tagged-
random primer p has a region with low AES on g. We design additional tagged-random primer q such that 
it has high AES in that region. 
 
2.7 Conclusion 
New generation genomic and diagnostic applications require the amplification of a wide range of 
known viruses and potentially novel viruses as an initial step. As it is not cost-effective to design 
specific primers for all known viruses and quite impossible to design specific primers for yet to 
be known viruses, tagged-random primer amplification is preferred over primer-specific 
amplification. However, genome-wide amplification bias of tagged-random primers is a serious 
yet commonly overlooked problem. 
In this chapter, we described a model to predict the amplification efficiency of a random-
tagged primer given a target genome(s). The AES provided us with a measurement that we can 
use to compare the amplification efficiency of different tagged-random primers on the target 
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genome. This paved the way for the development of LOMA, a fast and effective tagged-random 
primer generator. Through experiments, we have shown that the random-tagged primer 
generated by LOMA performs significantly better than a commonly used random-tagged primer 
on different genomes. Furthermore, LOMA is able to generate good tagged-random primers 
much faster than randomized approaches. 
Unlike specific primers that are almost always selected from the target genome under 
stringent primer design criteria [85], people tend to use tagged-random primers without checking 
their suitability with the target genome. This is a serious oversight that may cause inaccuracies in 
downstream work such as microarray analysis. Our research has shown that the blind use of a 
tagged-random primer in a PCR reaction on a virus sample may not lead to a successful 
amplification. Thus, the design of tagged-random primers is an important consideration when 
performing PCR and should be a common practice when using tagged-random primers. 








VIRUS DETECTION AND IDENTIFICATION 
3.1 DNA Microarrays in Virus Detection 
Developed in the 1990s, DNA microarrays detect and identify viruses through hybridization of 
their DNA against millions of oligomers (known as probes). Since each probe is designed to 
hybridize only to its intended sequence, we can easily determine if a particular virus is present in 
the sample by analyzing its probes (Figure 8). Hence by analyzing different sets of probes, 
microarrays have the ability to detect multiple viruses in a single experiment, co-infections and 
novel virus infections. Currently, viral detection by microarrays can rapidly decrease laboratory 
turnaround times so that results can be available within 2–6 hours. Future developments may see 
this reduced even further; and through the development of point-of-care devices, perhaps enable 
the clinician to make the diagnosis directly at the bed-side [86]. This would no doubt reduce 
morbidity and mortality, for example, through the earlier implementation of appropriate 
antimicrobial treatment. 
While pathogen microarrays and their utility in discovering emerging infectious diseases 
such as SARS have been described, technical problems related to accuracy and sensitivity of the 
assay prevent their routine use in patient care [87, 88, 89, 90]. For microarrays to become a 
standard diagnostic tool, the following questions must be addressed: (1) What are the factors that 
influence probe design and performance? (2) How is a pathogen “signature” measured and 
detected? (3) What is the specificity and sensitivity of an optimized detection platform? (4) Can 
detection algorithms distinguish co-infecting pathogens and closely related viral strains [91, 92]? 
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Figure 8: Microarray hybridization process. Viral RNA is first reversed transcribed to cDNA. The cDNA 
is then amplified, fragmented, end-labeled with biotin and applied to the microarray. The cDNA binds to 
complementary probes on the microarray, a process known as hybridization. A special scanner is then 
used to measure the fluorescent areas on the microarray. Probes that successfully bind to the cDNA 
fragments will generate a very bright fluorescent area, thus indicating what viruses are present in the 
sample. 
 
Noisy signals caused by cross-hybridization artifacts present a major obstacle to the 
interpretation of microarray data, particularly for the identification of rare virus sequences 
present in a complex mixture of nucleic acids [93]. For example, in clinical specimens, 
contaminating nucleic acid sequences such as those derived from the host tissue, will cross-
hybridize with virus-specific microarray probes above some threshold of sequence 
complementarities. This can result in false-positive signals that lead to erroneous conclusions. 
Similarly, the virus sequence, in addition to binding its specific probes, may cross-hybridize with 
other non-target probes (i.e., designed to detect other viruses). This latter phenomenon, though 
seemingly problematic, could provide useful information for virus identification to the extent 
Virus 





that such cross-hybridization can be accurately predicted. With various metrics to assess 
annealing potential and sequence specificity, microarray probes have traditionally been designed 
to ensure maximal specific hybridization (to a known target) with minimal cross-hybridization 
(to non-specific sequences). However, in practice we have found that many probes, though 
designed using optimal in silico parameters, do not perform according to expectations for reasons 
that are unclear. 
 
3.2 Design of Virus Recognition Probe Sets 
The accuracy and sensitivity of a pathogen detection microarray depend on its composition of 
probes. The practicality of a microarray as a low-cost pathogen detection tool also places a 
restriction on the number of probes that can be included on the microarray. Hence, the selection 
of a minimal number of “good” probes that can detect and identify a set of viruses of interest, to 
be synthesized onto the microarray is vital. The main challenge in probe design involves 
selecting probes that bind only to their intended cDNA and not to others (cross-hybridizations). 
In addition, proper probe design must also take into account other factors such secondary 
structure formation, CG-content and melting temperatures of probes that may cause 
hybridization errors [94].  
 
3.2.1 Empirical Determination of Cross-Hybridization Thresholds of Probes 
To systematically investigate the dynamics of array-based pathogen detection, we created an 
oligonucleotide array using Nimblegen array synthesis technology [95]. The array was designed 
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to detect up to 35 RNA viruses using 40-mer probes tiled at an average 8-base resolution across 
the full length of each genome. Together with 7 replicates for each viral probe, and control 
sequences for array synthesis and hybridization, the array contained a total of 390,482 probes. 
Initially, we studied virus samples purified from cell lines, reverse-transcribed and PCR-
amplified with virus-specific primers (instead of random primers). This allowed us to study array 
hybridization dynamics in a controlled fashion, without the complexity of cross-hybridization 
from human RNA and random annealing dynamics which occur with random primers. We then 
applied our findings to clinical samples amplified using random primers. 
 
Figure 9: Heatmap of microarray probe signal intensities. Cells corresponding to probes are aligned in 
genomic order and colored according to the signal intensity-color scales shown. Hybridization signatures 
corresponding to SARS Sin850 (a) and Dengue I Hawaiian isolate (b) are shown.  
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SARS coronavirus and Dengue serotype 1 genomic cDNA were amplified in entirety (as 
confirmed by sequencing), labeled with Cy3 and hybridized separately on microarrays. The 
SARS sample hybridized well to the SARS tiling probes, with all 3,805 SARS-specific probes 
displaying fluorescent (Cy3) signal well above the detection threshold (determined by probe 
signal intensities > 2 standard deviations (SD) above the mean array signal intensity; Figure 9a). 
Cross-hybridization with other pathogen probe sets was minimal, observed only for other 
members of Coronaviridae and a few species of Picornaviridae and Paramyxoviridae, consistent 
with the observation that SARS shares little sequence homology with other known viruses [96]. 
The hybridization pattern of Dengue 1, on the other hand, was more complex (Figure 9b). First, 
we observed that hybridization to the Dengue 1 probe set was partially incomplete (i.e., regions 
absent of signal) due to sequence polymorphisms. The Dengue 1 sample hybridized on the array 
was cultured from a 1944 Hawaiian isolate, whereas the array probe set was based on the 
sequence of a Singaporean strain S275/90, isolated in 1990 [97]. Sequencing the entire genomes 
of these 2 isolates revealed that the array probes which failed to hybridize each contained at least 
3 mismatches (within a 15-base stretch) to the sample sequence. Second, we observed that cross-
hybridization occurred to some degree with almost all viral probe sets present on the array, 
particularly with probes of other Flaviviridae members, consistent with the fact that the 4 
Dengue serotypes share 60-70% homology. To understand the relationship between 
hybridization signal output and annealing specificity, we first compared all probe sequences to 
each viral genome using 2 measures of similarity: probe hamming distance (HD) and maximum 
contiguous match (MCM). HD measures the overall similarity distance of two sequences, with 
low scores for similar sequences [98, 99]. MCM measures the number of consecutive bases 
which are exact matches, with high scores for similar sequences [99, 100]. 
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We calculated the HD and MCM scores for every probe relative to the Hawaiian Dengue 
1 isolate and observed that these scores were negatively correlated (HD) and positively 
correlated (MCM) to probe signal intensity (Figure 10). All probes on the array with high 
similarity to the Hawaiian Dengue I genome, i.e. H ≤ 2 (n = 942) or MCM ≥ 27 (n = 627), 
hybridized with median signal intensity 3 SD above detection threshold. Although 98% of probes 
were detectable at the low HD range from 0-4, or high MCM range from 18-40, median probe 
signal intensity decreased at every increment of sequence distance (Figure 10). Median signal 
intensity dropped off sharply to background levels at HD = 7 and MCM = 15, with 43% and 46% 
detectable probes, respectively. The majority of probes (> 96%, n > 51,000) had HD scores 
between 8-21 and/or MCM scores between 0-15, of which only 1.23% and 1.57% respectively, 
were detectable. 
At the optimal similarity thresholds HD ≤ 4 and MCM ≥ 18, > 98% of probes could be 
detected with median signal intensity 2 SD above detection threshold, whereas adjusting the 
similarity threshold down 1 step to HD ≤ 5 and MCM ≥ 17 would result in only ~ 85% probe 
detection and median signal intensity ~ 1.2 SD above detection threshold (Figure 10). Using 
these optimal HD and MCM thresholds to guard against cross-hybridization, we binned all 
probes into specific “recognition signature probe sets” (i.e., r-signatures) most likely to 
specifically detect a given pathogen, and we defined r-signatures for each of the 35 pathogen 
genomes represented on the array. Each pathogen’s r-signature comprised tiling probes derived 
from its genome sequence (HD = 0, MCM = 40), as well as cross-hybridizing probes derived 
from other pathogens (HD ≤ 4, MCM ≥ 18). According to these criteria, a given probe could 




Figure 10: Relationship between probe Hamming Distance (HD), probe Maximum Contiguous Match 
(MCM) and probe signal intensity. Average probe signal intensity and percentage of detectable probes 
(signal intensity > mean + 2 SD) decreases as HD increases and MCM decreases. The optimal cross-
hybridization thresholds HD ≤ 4 or MCM ≥ 18, where > 98% of probes can be detected, is shaded in blue. 
 
We next considered other non-specific hybridization phenomena that could affect 
performance of our r-signature probes. For example, we observed a linear relationship between 
probe signal and %GC content. Consistent with previous observations, we found that probes < 
40% GC hybridized with diminished signal intensities, while probes > 60% GC content showed 
higher signal intensities [50, 101]. Thus, we censored probes with GC < 40% or > 60% from the 
r-signatures, despite optimal HD or MCM values. Furthermore, as cross-hybridization with 
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human sequences could also confound results, we compared all probes to the human genome 
assembly (build 17) by BLAST using a word size of 15 [102]. Probes with expectation value of 
100 were also censored. 
While the ideal pathogen r-signature would be one where all probes would hybridize to 
the target sequence at detectable levels, polymorphic variation between the probes (derived from 
a consensus sequence) and the actual target would be expected to impede the performance of the 
r-signature probes at some level. To test this hypothesis, we compared the ratios of detectable to 
undetectable probes across all r-signatures in the context of the hybridization involving the 
Hawaiian Dengue 1 isolate. Although the Dengue 1 sequence used to derive the Dengue 1 r-
signature was ~ 5% different from the Hawaiian isolate, the detectable probe ratio of the Dengue 
1 specific probes was 151/152 (99%), 12 times higher then that for the nearest Dengue serotype 
signature, suggesting that moderate polymorphic variation is quite tolerable, allowing, in this 
case, for discernment of the correct pathogen. 
 
3.2.2 Genome-wide Amplification Bias and its Implications on Viral 
Detection 
Random priming amplification, rather than primer-specific amplification is preferred for 
identifying unknown pathogens in clinical specimens. However, in initial experiments using 
random priming amplification to identify known pathogens, we frequently observed incomplete 
hybridization of the pathogen genome marked by interspersed genomic regions not detected by 
the probes. An example of a hybridization heatmap from a microarray experiment involving the 
amplification of respiratory syncytial virus (RSV) B using a commercially available tagged-
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random primer (5’-GTT TCC CAG TCA CGA TAN NNN NNN-3’) is shown in Figure 11a. In 
preliminary analyses, sequence polymorphisms, probe GC content and genome secondary 
structure failed to explain why most probes did not light up, suggesting that it might be due to a 
PCR-based amplification bias stemming from differential abilities of the random primers to bind 
to the viral genome at the reverse transcription (RT) step. Hence, we used LOMA (described in 
chapter 2) to design an alternative primer (5-TAG GTC GGT GGG TAG GTN NNN NNN-3’) 
that had a much better AES (that takes into account dimer formation and melting temperatures 
[77, 103]) than the original primer. The microarray experiment was then repeated using the 
primer designed by LOMA for amplification of RSV B (Figure 11b). From Figure 11, it is clear 
that amplification of RSV B using the primer designed by LOMA resulted in a dramatic increase 
in the number of lighted-up probes as opposed to using the original primer. A similar observation 
was made when the two primers were used to amplify another virus (hMPV). 
 
Figure 11: Heatmap of probe signal intensity for a RSV B sample following random RT-PCR by original 
primer and LOMA designed primer. Red regions correspond to probes that did not have signal intensities 
above threshold. As probe signal intensity increases, the heatmap changes from red to orange to yellow to 
white. LOMA primer performs significantly better than the original primer as there are less red regions 
indicating that most probes had high signal intensities. 
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 The discovery and validation of amplification bias when using tagged-random primers 
have serious implications on viral detection via microarrays. We have shown that PCR 
amplification bias could cause entire regions of probes, regardless of probe homology, specificity 
and sensitivity properties, to fail to hybridize to its target sequences. Hence, proper probe design 
is no longer sufficient for an accurate interpretation of the microarray data. The tagged-random 
primer used for amplification must also be chosen with care. By ensuring the chosen tagged-
random primer has uniformly high AES over whole genome sequences of the target viruses, we 
can reduce the chances of probe signal inaccuracies and ultimately improve viral detection 
accuracy and confidence. 
 
3.3 PDA – A Statistical-Based Algorithm for Virus Detection 
We observed that while the signal intensities for all pathogen r-signatures approximate a normal 
distribution (Figure 12a). We reasoned that analysis of the tails of the signal intensity 
distributions for each r-signature might better enable not only the identification of an infecting 
pathogen, but also the presence of co-infecting pathogens in the same sample. Thus, we devised 
a robust statistics-based pathogen detection algorithm (PDA), which analyzes the distribution of 
probe signal intensities relative to the in silico r-signatures. The PDA software comprises 2 parts: 
(1) Evaluation of signal intensity of probes in each pathogen r-signature using a modified 
Kullback-Leibler Divergence (KL), and (2) statistical analysis of modified KL scores using the 
Anderson-Darling test.  
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Figure 12: Distribution of probe signal intensities and WKL scores. RNA isolated from a RSV-infected 
patient was hybridized onto the array. (A) Distribution of probe signal intensities of all 53555 probes 
(red) and r-signature probes for an absent pathogen, eg. parainfluenza-1 (dotted line) show a normal 
distribution. The distribution of signal intensity for RSV r-signature probes are positively skewed, with 
higher signal intensities in the tail of the distribution. (B) Distribution frequency of WKL scores for the 
35 pathogen r-signatures with majority ranging between -5 and 3. A non-normal WKL score distribution 
is observed (P<0.05 by Anderson Darling test). The presence of a pathogen is indicated by a non-normal 
distribution caused by outlier WKL=17, corresponding to RSV. Excluding the RSV r-signature WKL 
score results in a normal distribution. From this computation, we conclude that RSV is present in the 
hybridized sample. 
 
Consider the virus va. Let Pa be the set of probes of a virus va and aP = P - Pa. Let [rlow , 
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njf  is the fraction of probes in aP  
found in bin bj, jan  and 
j
a
n  are the number of probes in Pa and aP in the bin bj respectively. 
To compare the signal difference of the tail of the probability distribution, we set 
alowr µ= , the mean signal intensity of the probes in aP , and rhigh = maximum signal intensity. 
We set the default number of bins, c = 20. Since the original KL cannot reliably determine 
differences in the tails of a probability distribution, and is highly dependent on the number of 
probes per genome and the size of each signal intensity bin, we incorporated the Anderson-
Darling statistic to give more weight to the tails of each distribution. By using a cumulative 
distribution function instead of the original probability distribution, the p-value generated is 
independent of the binning criteria, eliminating errors which occur if a particular signal intensity 




































where )( jQa  is the cumulative distribution function of the signal intensities of the probes in Pa 
found in bin bj; )( jQa  is the cumulative distribution function of the signal intensities of the 
probes in 
aP  found in bin bj. R-signatures representing absent pathogens should have normal 
signal intensity distributions and thus relatively low WKL scores, whereas those representing 
present pathogens should have high, statistically significant outlying WKL scores (Figure 12b).  
Next, we claim that the distribution of WKL scores of all viruses va ∈ V is 
approximately normal if there is no virus present in a sample. We empirically verify if our claim 
is correct by a bootstrapping process: Let n be the number of viruses in V. For each virus vk ∈ V 
where k = 1, …, n, we choose |vk| probe signal intensities from a real dataset randomly with 
replacement to form a “perturbed” signal intensity distribution of vk. Such distribution can mimic 
the situation where virus vk is not present in the sample. Thereafter, n WKL scores are generated 
for the set of n viruses. Next, we check if the n WKL scores follow a normal distribution by the 
Anderson-Darling test for normality at 95% confidence interval. The bootstrap is repeated 
100,000 times. The distribution is found to be normal in more than 99% of the time. (NB: since 
there are 35 viral genomes represented on our microarray, n =35)  
Based on the above discussion, we can test if a sample contains virus(es) by making the 
following null and alternative hypothesis:  
H0: The distribution of WKL scores is normal, i.e. viruses are not present in the sample. 
H1: The distribution of WKL scores is not normal, i.e. at least 1 virus is present in the 
sample. 
We proceed to apply the Anderson-Darling test for normality on the distribution of WKL scores 
to reject H0 with 95% confidence interval. If p < 0.05, the WKL distribution is considered not 
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normal, implying that the pathogen with outlying WKL scores is present. Upon identification of 
a pathogen, that pathogen’s WKL score is left out, and a separate Anderson-Darling test is 
performed to test for the presence of co-infecting pathogens. In this manner, the procedure is 
iteratively applied until only normal distributions remain (i.e., p > 0.05). The PDA algorithm is 
extremely fast, capable of making a diagnosis from a hybridized microarray in less than 10 
seconds. Figure 13 shows the pseudo-code for our virus-detection algorithm. 
Figure 13: Analysis framework of pathogen detection microarray data. 
 
3.4 Microarray Performance on Clinical Specimens 
To assess the clinical utility of the pathogen prediction platform, we analyzed 36 nasal wash 
specimens according to the workflow illustrated in Figure 14. These specimens were obtained 
from children under 4 years of age with lower respiratory tract infections (LRTI) of which 14 
were hospitalized for severe disease and 22 with ambulatory LRTI. The clinical diagnosis of 
these patients was bronchiolitis or pneumonia. All 36 specimens had been previously analyzed 
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for the presence of hMPV, RSV A and B using real-time PCR. Twenty-one specimens tested 
positive for one or more viruses, while 15 were PCR-negative for all three. All specimens were 
analyzed by microarray in a blinded fashion (Table 1).  
 




Table 1: Comparison of microarray and real-time PCR performance in detection of pathogen genera 
(HRV, pneumovirus). ND=none detected. *Hospitalized patients. †RSV A patient samples. 
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As RSV A full-genome sequence is not published, our array was not designed to 
specifically detect this virus. Thus we first assessed array performance using only results from 
the 16 patients diagnosed with either hMPV or RSV B by PCR (Table 2). Of this cohort, the 
microarray correctly detected the presence of hMPV or RSV B in 13/16 samples. This 
corresponds to an assay specificity of 100%, sensitivity of 76%, and diagnostic accuracy of 94%. 
All 4 false negative samples (patient #374, 841, 892, 924) had Ct values > 33.5, which is near the 
detection limit of real-time PCR, and thus perhaps beyond the range of detection by microarray. 
 
 
Table 2: Comparison of microarray and real-time PCR performance in detecting RSV B or hMPV. 
ND=none detected. *Hospitalized patients. 
 
We next assessed array performance in the group of patients PCR-positive for RSV A 
(n=7) and PCR-negative for all tested viruses (n=15). The microarray made only 2 positive calls 
in this group, both for RSV B. Interestingly, both RSV B calls corresponded to high-titre RSV A 
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specimens by PCR (#414, 913) suggesting that certain probe sets can detect the presence of 
related, but unspecified, viruses. Analysis of the published RSV A partial genome sequence (923 
bp, GenBank ID: AF516119) revealed that 7 probes on our microarray had 100% identity to 
RSV A. We created an “RSV A r-signature” comprising these 7 probes, enabling the specific 
detection of RSV A by microarray in 4/7 patient samples PCR-positive for RSV A (#414, 832, 
913 and 924). Although the performance of this small r-signature was not as robust as the other 
virus r-signatures (median size: 249 probes), it suggested that it was feasible to pursue a “viral 
discovery” approach using r-signatures created to detect viruses at the family or genus level, that 
were related to those species already represented on the microarray. Specifically, we binned 
probes into family- or genus level r-signatures by relaxing our similarity criteria (to HD≤5 or 
MCM≥25) and selecting probes common to genome sequences within families and genera for 
the picornaviridae family, paramyxoviridae family, rhinovirus genus (HRV) and pneumovirus 
genus (inclusive of RSV and hMPV). 
Upon re-analysis of all 36 samples, we identified the presence of pneumovirus in 17 
specimens as expected (1 false positive, #283), and additionally detected the presence of HRV in 
9 specimens (Table 1). As HRV was a novel discovery, we re-screened all 36 samples by PCR 
and found HRV in 11 specimens. All 9 HRV calls by microarray were confirmed by PCR except 
for 1. This finding was intriguing given that the genomic diversity of the over 100 known 
rhinovirus serotypes makes detection by PCR notoriously difficult [106]. As the real-time PCR 
primers were capable of identifying only ~70% of rhinovirus strains, it is possible that the 
microarray correctly detected a rhinovirus strain that PCR failed to detect. Similarly, the 
pneumovirus genus detected in patient #283 could not be verified by RT-PCR, possibly owing to 
subtle genetic variations that prevented primer annealing. Thus, the greater genomic coverage 
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afforded by the microarray might, in some cases, provide a more sensitive and accurate detection 
capability than pathogen-specific PCR.  
Though the microarray identified the majority of HRV and RSV A samples using the 
genus-level r-signatures, the array failed to detect 3 samples positive for HRV and 3 positive for 
RSV A by real-time PCR. These false negatives had an average Ct value > 32, again suggesting 
a detection threshold close to that of real-time PCR. However, the microarray also made a 
number of accurate discoveries in the 30-35 Ct range, suggesting a considerable degree of 
detection variability in the titre range above a ~30 Ct equivalency. Notably, the microarray 
correctly detected the presence of co-infecting pathogens in 2 samples (#337, #832), 




DNA microarrays have the potential to revolutionize clinical diagnostics through their ability to 
simultaneously investigate thousands of potential pathogens in order to make a diagnosis. 
However, questions remain regarding their sensitivity and reliability. In this work, we 
investigated the myriad of factors that influence microarray performance in the context of virus 
detection in clinical specimens, and describe an optimized platform capable of identifying 
individual and co-infecting viruses with high accuracy and sensitivity that brings microarray 
technology closer to the clinic. 
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Future improvements will include significant reductions in microarray manufacturing and 
usage costs. Multiplex microarray formats and “re-usable” arrays are developing technologies 
that promise to drive down these costs. Furthermore, alternative technologies such as beads 
[107], microfluidics [108, 109] and nanotube microarrays [110], might provide advantages in 
both assay cost and speed relative to traditional microarray platforms. Technology considerations 
aside, the advantages of a highly parallel, nucleic acid-based screening approach for detecting 
disease pathogens are clear. Validations in larger patient cohorts and in diverse clinical settings 




RESEQUENCING OF VIRAL GENOMES 
4.1 Resequencing Microarrays as a Large-scale Bio-surveillance 
Tool  
Historically, sequencing of viral genomes is performed using standard dye termination 
technologies. These conventional sequencing technologies produce accurate data but are too 
slow, costly, labour-intensive and low throughput to be practical for large-scale epidemiologic or 
evolutionary investigations in viral outbreaks. In recent years, next-generation sequencing 
technologies that can produce millions of sequences at once have emerged. Through massive 
parallelization of the sequencing process, technologies such as 454 are able to achieve high 
throughput at a progressively lower cost. However, next-generation technologies that are more 
suited for deep sequencing of a few samples, become less cost-effective when used to sequence a 
large number of samples. Oligonucleotide resequencing microarrays that are capable of 
identifying nucleotide sequence variants may offer a low-cost rapid solution for whole-genome 
sequencing of viruses [111]. 
 In April 2009, a novel influenza virus (H1N1) emerged from Mexico and rapidly spread 
to the rest of the world [112]. The global infection quickly forced the World Health Organization 
(WHO) to declare the outbreak an pandemic. As of December 2009, more than 414000 
confirmed cases and nearly 5000 deaths worldwide have been reported (http://www.who.int/en/). 
Nevertheless, the 2009 H1N1 pandemic did provide an unique opportunity to find out if 
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resequencing microarrays can be used as a practical, large-scale tool for bio-surveillance. In fact, 
resequencing microarrays have already been used for detecting and subtyping influenza viruses 
in recent years [113, 114]. However, only sequences from partial fragments of the hemagglutinin 
(HA) and neuraminidase (NA) genes were obtained for analysis. Hence, the full genome 
sequencing of a influenza A virus using microarrays remains a novelty. 
To address if microarrays can be used as a practical, large scale resequencing tool, we 
have developed a system comprising customized sequence amplification primers, a 12-plex DNA 
resequencing array for 2009 influenza A H1N1 and an automated base-calling and variant 
analysis software (EvolSTAR). In subsequent sections, we describe the development of the 
various genetic analysis components, and their validation using clinical samples. 
 
4.2 Design of Resequencing Microarrays 
We generated a consensus sequence for each segment of the H1N1(2009) virus by aligning all 
1715 complete and partial sequences available from the NCBI H1N1 flu resources database 
(http://www.ncbi.nlm.nih.gov/genomes/FLU/SwineFlu.html) as of June 11th 2009 using MAFFT 
[115] with high accuracy option.  
Tiling probes spanning the entire genome segments on both the forward and reverse 
strands were created at 1 base resolution [50]. Analysis of the sequence alignments revealed that 
there were no deletions, insertions or recombination. However, we found 36 mutation hotspots in 
the alignments where mutations occurred near one another (within 20 bp). A perfect match (PM) 
probe residing in a mutation hotspot may contain mismatches that will have a detrimental effect 
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on its hybridization intensity. To avoid this problem, we designed additional PM probes that 
contain all possible combinations of mutations found in each mutation hotspot. Thus, if 2 
mutations are found within 20bp of each other in the alignments, then we need in total 4 (22) PM 
probes to encode them. In general, 2x PM probes are needed to completely encode a cluster of x 
mutations that occur within 20bp of one another in the alignments. 
 
Furthermore, to ensure that we have accurate sequence of the drug binding pocket 
targeted by neuraminidase inhibitors [116] such as oseltamivir (Tamiflu®) and zanamivir 
(Relenza®) in the neuraminidase gene of the H1N1(2009) virus, additional probes were added. 
In total, the array contains 8,236 control probes and 121,928 H1N1(2009) probes, which 
provides 2x coverage of the entire H1N1(2009) genome, and up to 8x coverage of the regions 
comprising the 36 mutation hotspots and 10 drug-binding sites. 
 
4.3 Optimization of RT-PCR Primers and Conditions 
Due to the small amount of virus present in samples relative to human or cell-line total RNA, it 
was necessary to amplify the viral RNA through PCR. We employed a combination of sequence-
specific and random PCR approaches using LOMA-optimized primers as previously described in 
chapter 2. The addition of random primers ensured complete genome amplification, even if 
mutations were present at the specific-primer binding sites. PCR conditions were optimized by 
conducting 5 duplicate hybridizations of the same virus sample cultured from a patient sample 
under different PCR conditions. The optimized method was then tested on RNA isolated directly 
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from nasal swabs obtained from the same patient and from virus grown in cell culture. 
Microarray sequences generated from these replicate experiments were compared with capillary 
sequencing to estimate sequencing accuracy. 
 
4.4 Evolution Surveillance and Tracking Algorithm for 
Resequencing arrays 
Following PCR product labeling, hybridization and scanning, signal intensities for each probe 
was generated using Genepix 4.0 software, and annotated using Nimblescan 2.5 software. 
Initially, the standard Nimblescan software which employs a gain-of-signal approach (PBC 
algorithm [50]), was used to determine the viral sequence. The PBC algorithm assumes that the 
signal intensity of the perfect match (PM) probe (which matches exactly to the sequence in the 
sample) will be significantly higher than that of the mismatch (MM) probes. While this approach 
sufficed for ~90% of base queries, we observed that the discrimination between the PM and MM 
signals was not clear for the remaining probes. 
These ambiguous signals were caused by the presence of multiple mutations in the probe 
sequence, homopolymers and hybridization artifacts. We developed a novel algorithm, Evolution 
Surveillance and Tracking Algorithm for Resequencing arrays (EvolSTAR), to resolve this 
problem. EvolSTAR improves upon PBC by adding an analysis of the neighbourhood 




4.4.1 Neighbourhood Hybridization Intensity Profile 
Due to the use of tiling probes in resequencing arrays, a single nucleotide mutation at a particular 
query base could cause a dramatic reduction in the hybridization intensities of neighbouring PM 
probes up to 6 bases away [58]. This effect can be measured by studying the neighbourhood 
hybridization intensity profile (NHIP) of each query base. We defined the NHIP of each query 
base as the observed pattern of hybridization intensities of its PM and MM probes and 
neighbouring (± 6 bases from query base) PM and MM probes. To study the effects of sequence 
variation (mutation) and noise on the NHIP of a query base, we sequenced RNA from 
H1N1(2009) patient 380 by capillary sequencing and on duplicate microarrays. We compared 
sequence calls generated using by Nimblescan or by capillary sequencing and compiled a list of 
true (correct) calls, error calls and ‘N’ (unknown) calls. In total, of the expected 13588 bases of 
the H1N1 virus (based on genome described at 
http://www.ncbi.nlm.nih.gov/genomes/taxg.cgi?tax=211044) the microarray called 13449 bases 
while capillary sequence was able to call 12832 bases. 
By analyzing base calls from PBC that have been confirmed by capillary sequencing, we 
identified five distinct types of neighbourhood hybridization intensity profile belonging to true 
non-mutations (wild-type), true mutations, isolated errors/’N’s, long consecutive errors/’N’s, and 
unknown errors/’N’s respectively. For each non-high confidence query base, we determine the 
type of its NHIP by the following criteria: 
a) True-non-mutation – The PM probe (of both strands) of the query base must be a high 
confidence call (i.e., it has hybridization intensity ≥ 1.4 fold that of its MM probes). 
Neighbourhood PM probes are also high confidence calls. Let the mean hybridization 
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intensity of the three nearest PM probes to the immediate left of the mutation base (at 
position -1, -2 and -3), denoted as µ{-1,-2,-3}, the mean hybridization intensity of the three 
PM probes to the far left of the mutation base (at position -4, -5 and -6), denoted as µ{-4,-5,-
6}, the mean hybridization intensity of the three nearest PM probes to the immediate right 
of the mutation base (at position 1, 2 and 3), denoted as µ{1,2,3}, and the mean 
hybridization intensity of the three PM probes to the far right of the mutation base (at 
position 4, 5 and 6), denoted as µ{4,5,6}. We impose that µ{-1,-2,-3} ≈ µ{-4,-5,-6} and µ{1,2,3} ≈ 
µ{4,5,6} . 
b) True-mutation – The PM probe (of both strands) of the query base must have 
hybridization intensity ≥ 1.4 fold that of its MM probes. To detect the characteristic dip, 
we check 4 mean hybridization intensities: the mean hybridization intensity of the three 
nearest PM probes to the immediate left of the mutation base (at position -1, -2 and -3), 
denoted as µ{-1,-2,-3}, the mean hybridization intensity of the three PM probes to the far left 
of the mutation base (at position -4, -5 and -6), denoted as µ{-4,-5,-6}, the mean 
hybridization intensity of the three nearest PM probes to the immediate right of the 
mutation base (at position 1, 2 and 3), denoted as µ{1,2,3}, and the mean hybridization 
intensity of the three PM probes to the far right of the mutation base (at position 4, 5 and 
6), denoted as µ{4,5,6}. If µ{-1,-2,-3} < µ{-4,-5,-6} and µ{1,2,3}< µ{4,5,6}, we say this is a dip pattern 
and the query base is likely to be mutated. 
c) Isolated error/’N’ – The PM probe (of both strands) of the query base has hybridization 
intensity < 1.4 fold that of its MM probes. Neighbourhood PM probes are high 
confidence calls. 
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d) Long consecutive errors/’N’s – The PM probe (of both strands) of the query base has 
hybridization intensity < 1.4 fold that of its MM probes. A majority of neighbourhood 
PM probes are non-high confidence calls. 
e) Unknown error/’N’ – All other neighbourhood hybridization profile patterns that do not 
fall under the previous categories. 
 
 
Figure 15: Observed neighborhood hybridization intensity profiles for true-non-mutation calls. A 
representative set of observed NHIPs for true-non-mutation calls from patient sample 380. This 
representative set consists of 5 true-non-mutation calls randomly selected from each segment. Each line 
represents the NHIP (± 6 bp from query base position) of a true-non-mutation call. 
 
Figure 15 shows the NHIPs of a representative set of 40 randomly selected query bases 
that result in true-non-mutation calls (wild-type calls). We observed that in these NHIPs, the PM 
probe of the query base together with neighbouring PM probes, have hybridization intensities 
 65
significantly higher (> 1.4-fold) than that of their MM probes in general. We also identified 10 
mutations using capillary sequencing in the patient sample. The NHIPs of these 10 true-mutation 
calls (Figure 16) are very different from NHIPs of wild-type calls. The presence of a mutation at 
the query base created a mismatch in neighbouring PM probes and caused a drop in their 
hybridization intensities. The closer this mutation is to the centre of a neighbouring PM probe, 
the bigger the drop in hybridization intensity. This results in a distinctive dip to the immediate 
left and right of the centre of the NHIP where the mutation is. 
 
 




Figure 17: Observed neighborhood hybridization intensity profiles for unknown error/’N’ calls. A 
representative set of observed NHIPs for unknown error/’N’ calls from patient sample 380. This 
representative set consists of 2 unknown error/’N’ calls randomly selected from each segment. 
 
Unlike the NHIPs of wildtype and true-mutation calls, the NHIPs of most errors and ‘N’ 
calls appear haphazard (Figure 17). However, when we traced the locations of these errors and 
‘N’ calls on the genome, we found that some are isolated among good calls while others are 
conjugated in a small locality of the genome. We investigated the NHIPs of isolated errors and 
‘N’ calls that occurred among good calls and found that in these NHIPs, only the PM probe of 
the query base that is an error or ‘N’ call has poor hybridization differentiation with its MM 
probes while other PM probes have hybridization intensities significantly higher than that of 
their MM probes in general (Figure 18). This suggests that for such calls, only the PM and MM 
probes of the query base are noisy while neighbouring PM and MM probes are unaffected. In 
addition, we also found that long chains of consecutive error and ‘N’ calls (especially at the 5’ 
and 3’ end of the sample sequences) often have NHIPs where the PM probe of the query base 
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together with neighbouring PM probes, have poor hybridization differentiation with their MM 
probes (Figure 19). These error and ‘N’ calls usually occur at the ends of the genome segments. 
In summary, NHIP analysis showed that all true mutation calls had a characteristic profile 
(Figure 20b) that differed from wild-type sequence calls (Figure 20a). Ambiguous calls arising 
from different causes, such as homopolymers, isolated errors and hybridization artifacts also 
have profiles that are distinct from true mutation profiles (Figure 20). 
 
 
Figure 18: The observed NHIPs for all 3 identified isolated error/’N’ calls from patient sample 380. 




Figure 19: The observed NHIPs for 5 regions where there are long consecutive (≥ 5) error/’N’ calls from 
patient sample 380. 
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Figure 20: Summary of the characteristics of the NHIP for five types of call (true-non-mutation, true-
mutation, isolated error or ‘N’, long chains of consecutive errors or ‘N’, unknown error or ‘N’) based on 
their respective observed neighbourhood hybridization intensity profiles. The PM probe (red circle) of 
query base is at position 0 while neighbourhood PM probes (black circles) are numbered according to 
their distance away from the query base. A PM probe is significantly differentiated from its MM probes if 




4.4.2 Nucleotide Substitution Bias 
The presence of nucleotide substitution bias in Nimblegen resequencing arrays has been 
previously described [117]. However, this knowledge has so far been used only to improve probe 
design. In this paper, we propose a novel method that makes use of nucleotide substitution bias 
in the array to improve base-calling accuracy and call rate. The key idea is to build a likelihood 
model of the substitution bias among the probes of non-ambiguous calls on the array; then use 
this to call bases with ambiguous signals.  
To build the likelihood model, we first determined the substitution bias on our platform 
by comparing the PM and MM probes (of both strands) of 25028 true calls made by PBC from 
the two replicate microarray experiments of patient sample 380 mentioned in the previous 
section. For each true call, we generated a hybridization intensity reduction order by ranking the 
PM and MM probes of a particular strand in decreasing order of hybridization intensity and 
recording their respective frequencies (Table 3). Table 3 shows that for each PM probe encoding, 
certain hybridization intensity reduction orders occur much more frequently than others. For 
example, if the PM probe encoding is ‘A’ (regardless of strand), then it is most likely that the 
hybridization intensity reduction order is ‘TGC’ or ‘GTC’. Thus, by matching the hybridization 
intensity reduction orders of its PM/MM probes with that in Table 3, we can compute the 











Forward strand Reverse strand 
Frequency Frequency 
A 
CGT 547 246 
CTG 558 237 
GCT 957 367 
GTC 2215 1407 
TCG 1049 611 
TGC 3015 2873 
C 
AGT 2035 2712 
ATG 1752 2400 
GAT 382 341 
GTA 159 134 
TAG 360 377 
TGA 165 129 
G 
ACT 1474 1043 
ATC 976 624 
CAT 1639 1534 
CTA 868 788 
TAC 594 410 
TCA 542 454 
T 
ACG 432 529 
AGC 562 636 
CAG 623 841 
CGA 1066 1616 
GAC 1421 1878 
GCA 1637 2841 
 
Table 3: Hybridization intensity reduction orders found in two replicated hybridization experiments of 
patient sample 380. Hybridization intensity reduction orders found in 25028 true calls from two replicated 
hybridization experiments of patient sample 380. For each true call, for each strand, we rank the PM 
probe and its MM probes based on their hybridization intensities in decreasing order. We count the 
frequency of each hybridization intensity reduction order. 
 
Specifically, we define that a probe encodes the base b if b is located in the centre-most 
position of the probe and is the base to be interrogated. For a given query base, suppose the PM 
probe encodes b1 while the MM probes encode b2, b3 and b4 respectively where {b1, b2, b3, 
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b4}={A, C, G, T} and the hybridization intensity reduction order is b1b2b3b4. To validate if the 
observed PM probe encoding b1 is indeed the true PM probe of the sample sequence, we 
compute the likelihood ratio of fobs and frand, where fobs is probability of observing the 
hybridization intensity reduction order b1b2b3b4 given that the PM probe encodes b1 and frand is 
















)(#)(#)(# 433221 ××=  
where #(wxyz) is the number of observed hybridization intensity reduction orders from high 
confidence base calls and t is the total number of hybridization intensity reduction orders 
excluding b1b2b3b4 obtained from high confidence base calls. If the likelihood ratio > 2, we 
expect that the observed PM probe encoding b1 is indeed the true PM probe of the sample 
sequence. In this way, we can recover base calls of ambiguous query bases exceeding a 
reasonably high likelihood threshold and achieve better accuracy and call rate than PBC. 
 
4.4.3 Grading the Quality of the Sequence Calls 
EvolSTAR employs a two-step process for base-calling (Figure 21).  In the first step, each base 
query is scrutinized for signs of hybridization intensity abnormalities. If the gain-of-signal of the 
query base is strong and has no mutation, the base is called. In the second step, EvolSTAR then 
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tries to recover base queries that have any hybridization intensity abnormalities with two analysis 
methods, namely neighbourhood hybridization intensity profile analysis and nucleotide 
substitution bias analysis. 
 
Figure 21: Flowchart of EvolSTAR. Bold arrows are “Yes” paths, while normal arrows are “No” paths. 
In the first step, each base query is scrutinized for signs of hybridization intensity abnormalities. Base 
queries with hybridization intensity abnormalities are passed to step 2 for further analysis. 
 
Step 1: Identification of Base Queries with Ambiguity 
On our array platform, the hybridization intensity of each probe is given by the mean and 
standard deviation of the fluorescence intensities of 9 individually scanned pixels. Hence, we 
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define the signal-to-noise ratio (SNR) of a probe as the ratio of the mean to the standard 
deviation of the intensities of the 9 pixels associated with the probe. In our experiments, we 
found that >95% of all probes had SNR less than TSNR (TSNR = µSNR + 2σSNR where µSNR and 
σSNR are the mean and standard deviation of SNR of all probes on the array). The remaining 5% 
of probes with SNR ≥ TSNR are unreliable. Hence, base queries with one or more probes with 
SNR ≥ TSNR are analyzed further in step 2. Furthermore, all base queries whose PM probe in the 
forward strand and PM probe in the reverse strand are non-complementary, or have weak 
PM/MM hybridization intensity differentiation (< 1.4 fold) are also passed to step 2. Lastly, we 
also pass all putative mutation calls to step 2 for confirmation.  
 
Step 2: Mutation confirmation and base query recovery 
A high-confidence mutation call may be a result of coincidental non-specific hybridization of the 
same MM probe in both strands. As such, it may be inadequate to discern true mutations based 
solely on differences in the hybridization intensities of PM and MM probes. From our analysis of 
true-mutation calls made by PBC, we have found that true mutations have a signature NHIP type 
as per described in Figure 20(b). Thus, query bases that result in a mutation call must have this 
signature NHIP. Finally, to confirm the mutation, we perform nucleotide substitution bias 
analysis on these query bases. For each of the query bases with NHIP of type described in Figure 
20(b), we compute the likelihood ℓ that the observed PM probe (representing the mutation) is 
indeed the true PM probe of the sample sequence given the hybridization intensity-based 
ordering of its MM probes (see Method section). If ℓ > 2, the query base results in a strong 
mutation call (represented by upper case base calls ‘A’, ‘C’, ‘G’ or ‘T’). If ℓ > 1, the query base 
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results in a mutation call with weak support (represented by lower case base calls ‘a’, ‘c’, ‘g’ or 
‘t’). Otherwise, they are re-assigned an unknown ‘N’ call. 
For query bases that results in a mutation call but have NHIP of type described in Figure 
20(c), they are most likely isolated errors caused by poor PM probe quality. Hence, we correct 
the base-calls of these query bases to their respective reference bases (but represented by lower 
case base calls ‘a’, ‘c’, ‘g’ or ‘t’) in the reference sequences. We also perform the same 
correction to non-high-confidence query bases with NHIP of type described in Figure 20(c). 
We try to recover the remaining query bases that have NHIP of type described in Figure 
20(d) or Figure 20(e) by analyzing the substitution bias from their PM and MM probes in the 
forward and reverse strands separately. Similar to how a mutation is confirmed, we compute the 
likelihood ℓf that the observed PM probe (representing the unsure base call) is indeed the true PM 
probe of the sample sequence given the hybridization intensity-based ordering of its MM probes 
in the forward strand. We also compute a similar likelihood ℓr for the PM probe in the reverse 
strand. If the PM probes in both strands are complementary and ℓf, ℓr > 2, the query base results 
in a strong base call (represented by upper case base calls ‘A’, ‘C’, ‘G’ or ‘T’). However, in 
many cases, the PM probes in both strands are not complementary due to non-specific 
hybridization of MM probes in one or both strands. For such query bases, we make base calls 
based on ℓf and ℓr: If ℓf > ℓr and ℓf > 2, a base call with weak support (represented by lower case 
base calls ‘a’, ‘c’, ‘g’ or ‘t’) is made from the PM probe in the forward strand. Else, if ℓr > ℓf  and 
ℓr > 2, a base call with weak support is made from the PM probe in the reverse strand. Otherwise, 
they are assigned an unknown ‘N’ call. 
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Note that since nucleotide substitution biases may vary depending on the experimental 
conditions, experimental reagents or input samples, for each experiment, we obtain a set of high 
confidence base calls and use them to infer the hybridization intensity reduction orders for each 
PM probe encoding. This is then used to compute likelihood scores for base-calling non-high 
confidence query bases and mutation confirmation. 
 
4.5 Performance of EvolSTAR 
To validate the software, we hybridized 14 patient samples in duplicate onto the microarray. The 
microarrays were analyzed in parallel using Nimblescan (PBC algorithm) and EvolSTAR, and 
the sequences obtained were compared to Sanger capillary sequencing. We counted the number 
of true-non-mutation calls, true-mutation calls, error calls and ambiguous (‘N’) calls for both 
methods (Table 4). We also confirmed that the substitution bias in all 14 duplicate hybridization 
experiments (Table 5) were consistent with that found in Table 3. Compared with the available 
capillary sequences for the 14 samples, EvolSTAR had an average error rate of 0.0029% and 12 
ambiguous calls per sample (346 in total). This is far superior than Nimblescan PBC, where we 
obtained an average error rate of 0.083% and 158 ambiguous calls per sample (4434 in total). 
Furthermore, EvolSTAR called all true mutations correctly. The genome coverage attained by 
























EvolSTAR 1 4767 6 4737 6 0 0 
PBC 1 4767 6 4500 6 0 3 
EvolSTAR 2 4767 6 4737 6 0 0 
PBC 2 4767 6 4474 6 0 6 
141 
EvolSTAR 1 4051 6 4026 6 0 0 
PBC 1 4051 6 3832 6 0 10 
EvolSTAR 2 4051 6 4021 6 0 0 
PBC 2 4051 6 3808 6 0 4 
279 
EvolSTAR 1 693 2 670 2 0 0 
PBC 1 693 2 358 1 1 8 
EvolSTAR 2 693 2 682 2 0 0 
PBC 2 693 2 645 2 0 0 
354 
EvolSTAR 1 8950 9 8942 9 0 0 
PBC 1 8950 9 8802 9 0 1 
EvolSTAR 2 8950 9 8944 9 0 0 
PBC 2 8950 9 8851 9 0 0 
380 
EvolSTAR 1 12832 10 12803 10 0 0 
PBC 1 12832 10 12466 10 0 6 
EvolSTAR 2 12832 10 12816 10 0 0 
PBC 2 12832 10 12542 10 0 4 
384 
EvolSTAR 1 6002 6 5992 6 0 0 
PBC 1 6002 6 5888 6 0 0 
EvolSTAR 2 6002 6 5993 6 0 0 
PBC 2 6002 6 5895 6 0 1 
507 
EvolSTAR 1 3921 8 3913 8 0 0 
PBC 1 3921 8 3736 8 0 3 
EvolSTAR 2 3921 8 3916 8 0 0 
PBC 2 3921 8 3758 8 0 2 
581 
EvolSTAR 1 8574 10 8567 10 0 0 
PBC 1 8574 10 8458 10 0 2 
EvolSTAR 2 8574 10 8566 10 0 0 
PBC 2 8574 10 8461 10 0 5 
582 
EvolSTAR 1 3057 4 3051 4 0 0 
PBC 1 3057 4 2986 4 0 0 
EvolSTAR 2 3057 4 3053 4 0 0 
PBC 2 3057 4 3001 4 0 0 
593 
EvolSTAR 1 3054 3 3053 3 0 0 
PBC 1 3054 3 3007 2 1 0 
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EvolSTAR 2 3054 3 3053 3 0 0 
PBC 2 3054 3 2992 2 1 0 
9061364 
EvolSTAR 1 5129 5 5123 5 0 0 
PBC 1 5129 5 5064 5 0 0 
EvolSTAR 2 5129 5 5122 5 0 0 
PBC 2 5129 5 5042 5 0 0 
9061365 
EvolSTAR 1 3000 3 2993 3 0 0 
PBC 1 3000 3 2956 3 0 1 
EvolSTAR 2 3000 3 2991 3 0 0 
PBC 2 3000 3 2941 3 0 0 
9061366 
EvolSTAR 1 1683 3 1683 3 0 0 
PBC 1 1683 3 1649 3 0 1 
EvolSTAR 2 1683 3 1682 3 0 1 
PBC 2 1683 3 1636 3 0 1 
923 
EvolSTAR 1 4373 5 4365 5 0 0 
PBC 1 4373 5 4187 5 0 1 
EvolSTAR 2 4373 5 4330 5 0 1 
PBC 2 4373 5 3738 5 0 6 
 
Table 4: Comparison of Calls made by EvolSTAR and PBC for 14 samples. Types of calls and their 
frequencies generated by EvolSTAR and PBC in replicated microarray hybridizations of 14 patient 
samples. Partial or complete capillary sequences were generated for each sample and used to verify the 
calls made by EvolSTAR and PBC on each replicate. We then count the frequency of true-non-mutation, 
true-mutation, error and ‘N’ calls in each replicate. 
 
We wondered if, and by how much, incorporating NHIP and substitution biases analysis 
to the PBC results would improve the performance of the PBC algorithm.  We observed that 
more than 70% of the 65 error calls (false mutation calls) made by PBC did not have the 
characteristic NHIP of a true-mutation shown in Figure 20(b). The remaining 30% of the error 
calls had a NHIP reminiscent of a true-mutation NHIP but did not satisfy the substitution bias 
rule. Using NHIP and substitution biases analysis together, we were able to reduce the number of 
false mutation calls to only two.  Most of the 4434 ‘N’ calls made by PBC were due to 
conflicting base calls from the forward and reverse strand. By analyzing the NHIP and 
hybridization intensity reduction order of the query base in the forward and reverse strand 
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individually, we were able to identify the noisy strand and hence, make the base call only from 








Forward strand Reverse strand 
Frequency Frequency 
A 
CGT 2618 1030 
CTG 2347 975 
GCT 4848 1870 
GTC 12571 8889 
TCG 4417 2624 
TGC 16805 16692 
C 
AGT 10843 14309 
ATG 10606 14473 
GAT 1777 1567 
GTA 748 618 
TAG 2006 1784 
TGA 790 623 
G 
ACT 9114 7403 
ATC 5490 3647 
CAT 9369 8811 
CTA 4104 3143 
TAC 2839 1976 
TCA 2458 1790 
T 
ACG 1926 2080 
AGC 2489 2524 
CAG 3211 3721 
CGA 6191 8656 
GAC 7550 9533 
GCA 10713 17092 
 
Table 5: Hybridization intensity reduction orders found in 14 hybridization experiments. Hybridization 
intensity reduction orders found in 135830 true calls from 14 hybridization experiments. For each true 
call, for each strand, we rank the PM probe and its MM probes based on their hybridization intensities in 
decreasing order. We count the frequency of each hybridization intensity reduction order. 
 
 80






















EvolSTAR 1 6676 9 6601 9 0 0 
PBC 1 6676 9 6066 9 0 32 
EvolSTAR 2 6676 9 6569 9 0 1 




EvolSTAR 1 6676 9 6667 9 0 0 
PBC 1 6676 9 6515 9 0 3 
EvolSTAR 2 6676 9 6659 9 0 0 




EvolSTAR 1 6676 9 6652 9 0 0 
PBC 1 6676 9 6495 9 0 6 
EvolSTAR 2 6676 9 6656 9 0 0 




EvolSTAR 1 6676 9 6664 9 0 0 
PBC 1 6676 9 6551 9 0 4 
EvolSTAR 2 6676 9 6663 9 0 0 




EvolSTAR 1 6676 9 6658 9 0 0 
PBC 1 6676 9 6531 9 0 6 
EvolSTAR 2 6676 9 6664 9 0 0 




EvolSTAR 1 6676 9 6660 9 0 0 
PBC 1 6676 9 6571 9 0 3 
EvolSTAR 2 6676 9 6660 9 0 0 
PBC 2 6676 9 6523 9 0 5 
 
Table 6: Comparison of Calls made by EvolSTAR and PBC for 6 pairs of isolates belonging to patient 
sample 305. Types of calls and their frequencies generated by EvolSTAR and PBC in replicated 
microarray hybridizations of sample 305. Partial or complete capillary sequences were generated for each 
sample and used to verify the calls made by EvolSTAR and PBC on each replicate. We then count the 
frequency of true-non-mutation, true-mutation, error and ‘N’ calls in each replicate. 
 
In addition, we evaluate the robustness and repeatability of EvolSTAR by employing six 
pairs of replicate experiments consisting of one pair nasal swab and five pairs of cell culture 
isolates, belonging to the same patient sample 305 (Table 6). Of the experiments, two pairs of 
replicates (305_nasal and 305_cell_cond1) were amplified under the same optimal experimental 
conditions while each of the other pairs (305_cell_cond2, 305_cell_cond3, 305_cell_cond4, 
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305_cell_cond5) were amplified under different sub-optimal experimental conditions (simulating 
experimental volatility). Compared with the available capillary sequences for sample 305, 
EvolSTAR had an average error rate of 0.0012% and 28 ambiguous calls per sample (338 in 
total). On the other hand, Nimblescan PBC obtained a relatively higher average error rate of 
0.169% and 237 ambiguous calls per sample (2855 in total). Our results showed that EvolSTAR 
is robust and performs well when samples are prepared under sub-optimal conditions. Even for 
nasal swab samples that tend to have much less concentration of virus RNA than cell cultures, 
EvolSTAR suffered only a slight drop in performance compared to Nimblescan PBC. 
In conclusion, we have shown that EvolSTAR is robust and generates sequence calls of 
high accuracy and reproducibility in this pilot study consisting of 40 microarray experiments. 
Meanwhile, efforts will be put in to continually evaluate EvolSTAR with more samples and 
update it on a regular basis as the H1N1 (2009) influenza virus evolves. 
 
4.5.1 Visualization of Sequence Calls 
Besides a FASTA output of the virus sequence, EvolSTAR generates a visualization map of the 
sequence calls using a heat map based on the percentage identity of the called sequence to the 
reference sequence measured at 50 bp windows (Figure 22). The map template consists of all 
eight segments of the 2009 influenza A(H1N1) virus and the locations of known drug binding 
sites (marked with green lines) on the neuraminidase gene. Locations of all mutation calls are 
denoted by red triangles beneath the heat map bar. Sequences that are of low coverage (< 90%) 
are automatically flagged, and the overall PM/MM discrimination ratio for each segment is 
displayed. The heat map bar allows the technician to rapidly assess the quality of the sequence 
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data obtained from the microarray and identify regions where PCR did not work well, or 
presence of potential recombination/reassortment events. Mutations, especially those in close 
proximity to drug binding sites, can be quickly visualized. Other details such as coverage, 
number of base calls successfully made, number of mutations and number of ‘N’ calls for each 
sequence call are also shown on the visualization map. 
 
 
Figure 22: Visualization map of all eight segments of the 2009 influenza A(H1N1) virus and the 
locations of known drug binding sites (marked with green lines) on the neuraminidase (NA) gene 
(Segment 6). A heat map bar is used to represent the quality and coverage of its sequence calls. The 
locations of all mutation calls made by EvolSTAR are represented by red triangles beneath the heat map 
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bar. Sequences with coverage < 90% are automatically flagged as “Low Coverage”. Other details such as 
Coverage: percentage of base calls successfully made, Match: number of base calls that match the 
reference sequence ie non-mutation base calls, Strong Mismatch: number of high confidence base calls 
that do not match the reference sequence ie mutation base calls, Weak Mismatch: number of low 
confidence base calls that do not match the reference sequence ie mutation base calls and Ns: number of 
‘N’ calls, for each sequence call are also shown on the visualization map. 
 
4.6 Discussion and Conclusion 
Traditional statistical and probabilistic sequence-calling techniques ascertain that a base call is of 
high confidence if they exceed pre-defined significance or probability thresholds. This approach 
works well for high confidence base calls but is inadequate to extract sufficient information from 
noisy base calls. It is also difficult to determine the validity of a mutation call purely based on 
the distribution of hybridization intensities of its PM and MM probes. In this work, we have 
described two new hybridization intensity analysis methods that enable us to confidently identify 
true mutations and recover some noisy base calls. Compared to PBC, EvolSTAR has achieved 
superior call rates and accuracies, especially in low concentration samples with high CT values. 
The robustness of the base calls enables our approach to be a practical large-scale evolutionary 
surveillance tool. 
Although we are confident that our resequencing array can successfully generate 
complete sequences for the H1N1(2009) virus and its variants at the current stage, we cannot rule 
out the possibility of reassortments between the H1N1(2009) virus and other influenza viruses. 
Clearly, our resequencing array cannot fully sequence such events and will generate sequences 
with poor quality and coverage of the reassorted segments. To investigate the effects of a 
reassortment event on our array, we independently amplified segments 1, 2, 3, 5, 6 and 7 of the 
2009 influenza A(H1N1) virus and segment 4 of a H3N2 influenza A virus, and hybridized them 
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onto our array. The visualization map of this experiment is shown in Figure 23. As expected, the 
sequence call for segment 4 (based on PM/MM probes from the segment 4 consensus of the 2009 
influenza A(H1N1) virus) is poor in quality and coverage. However, we observed that we were 
able to get good base calls from region 1150-1547. This region turns out to be the only 
significantly similar (70% matched) region between the segment 4 consensus of the 2009 
influenza A(H1N1) virus and segment 4 of a H3N2 virus (CY039087). This shows that 
identifying regions of high similarity between the 2009 influenza A(H1N1) virus with other 
influenza viruses and checking if these regions have good sequence calls may be a plausible way 
of detecting reassortments. The drawback of this approach is that it will fail to detect 
reassortment of certain segments where there are no regions of high similarity between the 
H1N1(2009) virus and the parental influenza virus. It is also difficult to annotate and 
differentiate every region that the H1N1(2009) virus and all other influenza viruses share 
similarity with. We propose an alternative approach to detect reassortments. By analyzing the 
PM/MM hybridization intensity fold-change of high confidence calls of all 8 segments, we found 
that the average PM/MM hybridization intensity foldchange of high confidence calls in segments 
1, 2, 3, 5, 6, and 7 belonging to the 2009 influenza A(H1N1) virus is approximately 4.5 while the 
average PM/MM hybridization intensity fold-change of high confidence calls in segment 4 
belonging to the H3N2 influenza A virus is only 1.9. The most likely reason for this huge drop in 
the average PM/MM hybridization intensity fold-change of high confidence calls is that the 
signal gained by most of the segment 4 PM probes on our array are through cross-hybridization 
to the segment 4 sequence of the H3N2 influenza A virus, and thus much lower than signal 
gained from true specific binding. Thus, by computing and comparing the average PM/MM 
hybridization intensity fold-change of high confidence calls in each segment, we can identify 
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potential reassortments in a given H1N1(2009) virus sample. Virus samples with possible 




Figure 23: Visualization map of a 2009 influenza A(H1N1) virus with artificial reassortment of H3N2 
segment 4. We independently amplified segments 1, 2, 3, 5, 6 and 7 of the 2009 influenza A(H1N1) virus 
and segment 4 of a H3N2 influenza A virus, and hybridized them onto our array. As expected, the 
sequence call for segment 4 (based on PM/MM probes from the segment 4 consensus of the 2009 
influenza A(H1N1) virus) is poor in quality and coverage. 
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 So far, the sequence diversity of H1N1 2009 influenza virus has been rather limited. 
From our analysis, it would be possible to resequence all the published isolates using this 
resequencing approach.  However, as antigenic drift is expected to occur, it is likely that the 
resequencing array would need to be updated at least annually.  Updating the array requires only 
bioinformatics input, and does not require any other additional manufacturing costs. Thus, this 
combination of sample amplification primers, low-cost multiplex array and robust interpretation 




RECOMBINATION DETECTION IN VIRAL GENOMES 
5.1 Sources of Inaccuracy of Distance-based Window Methods 
Accurate phylogenetic analysis gives us important clues on the origins, pathogenicity and 
treatments of viruses and bacteria. The first crucial step in carrying out an accurate phylogenetic 
analysis is the identification of recombination breakpoints. A breakpoint is defined as the 
location where a recombination event occurs in a sequence.  
A hugely popular technique is to slide a window along a sequence alignment and look for 
differences in distance metrics or phylogenetic trees within each window. More specifically, a 
length-w “sliding window” is defined as a window enclosing the alignments from positions i to i 
+ w. Suppose b is a breakpoint, we would expect the immediate left and right neighboring 
windows [b – w …b – 1], [b …b + w] of b to enclose alignments that are significantly different. 
Hence, to find the exact positions of the breakpoints (if any), the sliding window approach 
performs an exhaustive search by sliding a length-w window across the alignment and for every 
possible position i (w ≤ i ≤ N – w), it compares the alignments enclosed by neighboring windows 
[i – w …i – 1] and [i …i + w]. There are two main ways to compare alignments, namely by 
distance measures (distance-based) or phylogenetic trees’ topologies (phylogeny-based). 
Although phylogeny-based measures are widely accepted as more accurate than distance-based 
measures, distance-based measures are often much faster and more scalable for large datasets. 
However, for distance-based window methods to be as reliable as phylogeny-based methods, 
their accuracy issues must be addressed.  
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There are two sources of inaccuracy when using distance-based window methods to 
detect recombination. Firstly, the use of conventional distance metrics, such as hamming-
distance and edit-distance that measure overall homology results in phylogenetic information 
loss. Secondly, recombination detection is too sensitive on the choice of window length. Recent 
works have shown that their results are most accurate when the given window length is 
approximately the recombinant subsequence length [62, 64]. If the length of the recombinant is 
not known in advance, an algorithm using different window lengths may produce vastly different 
analysis results on the same dataset. Furthermore, there may be problems in detecting 
recombinant regions shorter than the given window length due to the noise caused by the original 
sequence on either side of the recombinant subsequence included in the window (Figure 24). 
 
Figure 24: Window length sensitivity problem when window length w is longer than the recombinant 
subsequence (S’2) length. (a) and (b) show the introduction of alignment noise into the computation of 
any distance measure or phylogenetic tree of the alignment in [i…i+w]. (c) shows the result of running 
Pruned-PDM on a synthetic dataset SD3 with breakpoints at site 1000, 2000, 3000 and 4000 using a 
length-500 window. (d) shows the result of running Pruned-PDM on the same dataset using a length-600 
window. Here, the breakpoints are inaccurately detected at sites 700, 2600, 3200 and 4200. 
 
To improve the information content of conventional distance measures and to reduce the 
impact of different window lengths on recombination detection, we employed three techniques:  
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1. Instead of using base-by-base comparison, the similarity of an alignment is computed 
using the number of shared (k,m)-mers, that is, length-k alignments with at most m 
mismatches. This measure takes into account the different mutation rates along the 
alignment by varying its mismatch threshold m automatically. This avoids the effect of 
random point mutations which causes inaccuracy in distance measures using base-by-
base comparison. 
 
2. Given a window instance, we use a weighting strategy that assigns heavier weights to 
positions nearer the putative breakpoint and lighter weights to positions further away 
from the putative breakpoint. This reduces the effect of alignment noise as seen in Figure 
24(a)(b) when computing the similarity score. 
 
3. Use contiguous chains of (k,m)-mers to form Contigs. Contigs have even distribution of 
mismatches and thus, are better estimations of long common subsequences in an 
alignment. 
 
5.2 Using (k, m)-mers as the Basic Unit of Similarity Measurement 
Conventional distance measures such as hamming-distance and edit-distance that perform base-
by-base comparisons are susceptible to noise caused by random mutations. Furthermore, they 
compute only overall sequence homology and omit important details about the distribution of 
mismatches and the distribution of contiguous matches that may provide further indication of 
recombination. A possible solution is to use shared (k,m)-mers as the basic unit of similarity 
measurement in place of base-by-base comparisons. 
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Definition 1. Let A
 
be a length-n alignment of two sequences S1, S2. Let A[x… x+k-1] be a 
length-k sub-alignment from position x to position (x + k-1) of A. A[x…x+k-1] is a shared (k,m)-
mer iff A[x…x+k-1] has less than m mismatches. This is shown in Figure 25. 
 
Essentially, by counting the number of shared (k,m)-mers, we can identify homologous 
regions of two sequences with an underlying rate of random mutation. Here, the selection of 
values for k and m is vital as k determines the specificity of homologous regions found and m 
estimates the underlying random mutation rate. Note that k should be small but at least of length 
(log2n + 1) to ensure specificity. Clearly, the selection of a global value for m is not feasible 
because the underlying rate of random mutations varies across the alignment. Hence, a localized 
value of m must be chosen for each sub-alignment enclosed by a window instance. We describe a 
heuristic to automatically determine m for a window instance: Given a length-w window 
[i…i+w] with parameters k and m, let Km and K’m be the number of shared (k,m)-mers and the 
number of non-shared (k,m)-mers respectively (note that Km + K’m = w – k + 1). Starting with m 
= 0, we iteratively increase m until Km > K’m. Denote }'|min{ mmi KKmm >= . At this point of time, 
a majority of (k,m)-mers in the window are shared (k,m)-mers having less than mi random 
mutations. This becomes a reasonable estimate of the underlying random mutation rate of the 




Figure 25: A diagram showing how shared (k, m)-mers are defined in each window of a putative 
breakpoint i of an alignment A of two sequences S1, S2. Top: Shared (k, m)-mers for [i-w…i-1] and 
[i…i+w] using mismatch thresholds mi,L = 1 and mi,R = 0 respectively. Bottom: After normalization (mi = 
1), the number of shared (5,1)-mers in each window reflects more accurately the relative sequence 
homology. Hence, kmdi,L = 13 and kmdi,R = 17. Note that consecutive shared (k, m)-mers form a Contig 
which we will elaborate in Section 5.1.2. 
 
To detect recombination in an alignment of two sequences S1 and S2, we compute and 
compare a similarity score based on the shared (k,m)-mers of the two neighboring windows [i-
w…i-1] and [i…i+w] of a putative breakpoint i. Let mi,L and mi,R  be the mismatch thresholds of 
[i-w…i-1] and [i…i+w] respectively. Clearly, we cannot compare any similarity score of [i-w…i-
1] and [i…i+w] when mi,L  ≠ mi,R . Thus, we need to normalize mi,L and mi,R  so that shared (k,m)-
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mers in [i-w…i-1] and [i…i+w] are defined based on a single mismatch threshold under the 
assumption of a common random mutation rate. Note that if i is a breakpoint or has high 
mutation rates, then the sequence homologies in the alignment enclosed by one window would 
be quite different from that enclosed in the other window (ie mi,L  ≠ mi,R). We exploit this 
observation and use the normalized mismatch threshold at i, mi = max(mi,L, mi,R) to define shared 
(k,m)-mers in both [i-w…i-1] and [i…i+w] (Figure 25). In this way, the window with the lower 
mismatch threshold will have many more shared (k,m)-mers than the other window with the 
higher mismatch threshold. Thus, any irregularities at i such as recombination and high mutation 
rates would be shown as a huge discrepancy in the number of shared (k,m)-mers in [i-w…i-1] 
and [i…i+w]. Formally, we denote the number of shared (k,m)-mers between S1 and S2 in each 
neighboring window of a putative breakpoint i as the km-distance (kmd): 
For the left window [i-w…i-1], kmdi,L(S1, S2) = |Pi,L| 
For the right window [i…i+w], kmdi,R(S1, S2) = |Pi,R| 
where Pi,L = {j | i-w ≤ j ≤ i-1-k and A[j…j+k-1] is a shared (k, m)-mer} and Pi,L = {j | i ≤ j ≤ i+w-k 
and A[j…j+k-1] is a shared (k, m)-mer}. Recombination is then inferred by some metric 
computed based on the magnitude of difference between kmdi,L and kmdi,R. This is further 
elaborated in Section 5.5. 
 
5.3 Contigs as a Better Estimation of Long Common Subsequences 
The previous section championed the use of shared (k,m)-mers over base-by-base comparisons 
when measuring homology between two sequences. However, they are too short to truly 
represent the degree of homology between two sequences. A better indication of homology 
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between two sequences would be the number and length distributions of long common 
subsequences. Now, the question is how do we obtain long common subsequences of two 
sequences enclosed by a window with only short shared (k,m)-mers? Note that a length-L 
common subsequence of S1 and S2 is a tiling of (L – k + 1) consecutive shared (k,m)-mers when k 
≤ L. In this paper, we define a common subsequence of S1, S2 as a chain of consecutive shared 
(k,m)-mers, which is known as a Contig. 
 
Definition 2. A Contig is a length-L common subsequence of two sequences S1 and S2 formed by 
a chain of consecutive shared (k,m)-mers shared by S1 and S2. It has two parameters, namely the 
starting position p and the member size s. Here, p refers to the position of the Contig nearest to a 
putative breakpoint i and s = L – k + 1, that is, the number of consecutive shared (k,m)-mers 
chained to form the Contig. Thus a Contig can be written as Contig(p, s). (See Figure 25) 
 
It is easy to see that any length-L’ sub-Contig of a length-L Contig where k ≤ L’ ≤ L is 
guaranteed to have less than (m/k * L’) mismatches. In addition, Contigs have an even 
distribution of mismatches. On the contrary, long common subsequences may have 
concentrations of mismatches in localized regions, despite passing the overall mismatch 
threshold. This creates a dilemma of whether to split a long common subsequence into shorter 
ones at regions where there are many mismatches. Our definition of Contigs avoids this problem 
and thus is more reflective of the localized similarity between two sequences.  
This leads to the assessment of a position i being a true breakpoint by two criteria: 
1. If i  is a breakpoint, the Contig length distributions in [i-w…i-1] and [i…i+w] will be 
significantly different due to the distinct difference in sequence homology of the 
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alignment enclosed by each window. Hence, we can assess if position i is a 
breakpoint by perform a Kolmogorov-Smirnov test [118] on the Contig length 
distributions in [i-w…i-1] and [i…i+w] at 99% confidence interval. 
 
2. There should be a significant difference between similarity scores computed for the 
alignment in [i-w…i-1] and [i…i+w]. 
Note that in the previous section, the km-distances, kmdi,L and kmdi,R, were used as the 
similarity scores for the alignment enclosed by [i-w…i-1] and [i…i+w]. Next section describes a 
weighting strategy to improve the km-distance to incorporate the concept of Contigs. Similarly, 
we elaborate on the metric to detect recombination in Section 5.5. 
 
5.4 Breakpoint Specific Positional Weighted Distance Measure 
Depicted in Figure 24(a)(b), the alignment noise affect the detection of breakpoint. We solve the 
issue by assigning weights to all positions enclosed by [i-w…i-1] and [i…i+w] with respect to a 
putative breakpoint i. More specifically, we assign heavier weights to positions in [i-w…i-1] and 
[i…i+w]
 
near to the putative breakpoint i while lighter weights to positions in [i-w…i-1] and 
[i…i+w]
  
that are further away from the putative breakpoint. We justify our proposed weighting 
strategy to solve the window length sensitivity problem based on Figure 24(a)(b):  In Figure 
24(a) where i is a true breakpoint, positions that are furthest away from i are most likely to 
contribute to alignment noise if the window length is too large. Thus, by assigning these 
positions the lightest weights when computing the km-distance for each window, alignment 
noise is reduced. In Figure 24(b) where i is not a true breakpoint, the alignment near i in [i-w…i-
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1] and [i…i+w] will not experience a sudden significant change. Since positions near i are 
assigned heavier weights, the km-distance in [i-w…i-1] and [i…i+w] will most likely not have a 
sudden significant change too. 
Clearly, a good implementation of our weighting strategy requires a suitable function or a 
suitable family of functions that assigns a weight to a position in neighboring windows [i-w…i-
1], [i…i+w] based on its absolute distance from a putative breakpoint i. Let S1 and S2 be two 
aligned length-n sequences with a putative breakpoint at position i with neighboring windows [i-
w…i-1], [i…i+w]. Let x be the relative distance of a position j in [i-w…i-1], [i…i+w] from the 
breakpoint i, that is x = j-i, and -w ≤ x ≤ w. Next, we define a positive weight function Fi : X 
→ +ℜ  where X = {x | -w ≤ x ≤ w}. Fi(x) satisfies the properties that (i) Fi(x) = Fi(-x) and (ii) Fi(x) 
is decreasing when |x| increases. For simplicity, we set Fi(0) = 1 and Fi(w) = Fi(-w) = 0. A family 






xF ||)( −=  
Note that k controls the decreasing rate of Fi(x). In our application, we need moderate 
decreasing rate and hence we set k=2 by default. In this case, Fi(x) is in fact a reverse parabola 
shape.  
Next, we describe how this weighting strategy incorporates the notion of Contigs in the 
km-distance. The idea is to assign a weight to each shared (k, m)-mer based on which Contig it 
belongs to. In this way, shared (k, m)-mers belonging to the more informative Contigs (closer to 
the putative breakpoint) are assigned heavier weights than those belonging to Contigs that are 
more prone to alignment noise (further away from the putative breakpoint). More specifically, 
our weighting strategy assigns each Contig(p, s) and its member shared (k, m)-mers a weight 
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Fi(|i-p|). Since Contigs do not overlap in a window, the weight assigned to each Contig and its 
member shared (k, m)-mers is unique. Consequently, given Contig(p1, s1) and Contig(p2, s2) with 
assigned weights Fi(|i- p1|) and Fi(|i- p2|) respectively, Fi(|i- p1|) > Fi(|i- p2|) iff |i- p1| < |i- p2|. 
Thus, given a putative breakpoint i and the two neighboring windows [i-w…i-1] and 
[i…i+w], we compute the improved Breakpoint specific positional Weighted Contig-Alignment 
(BWCA) score for the alignment of S1 and S2 in each neighboring window of a putative 
breakpoint i: 



















where Ci,L = {Contig(pj, sj) | i-w ≤ pj ≤ i -1} and Ci,R = {Contig(pj, sj) | i ≤ pj ≤ i + w} are the sets 
of Contigs in [i-w…i-1] and [i…i+w] respectively; Si,L = {sj | Contig(pj, sj) ∈ Ci,L} and Si,R = {sj | 
Contig(pj, sj) ∈  Ci,R} are the corresponding set of member sizes of the Contigs in Ci,L and Ci,R; 
Pi,L = {pj | Contig(pj, sj) ∈  Ci,L} and Pi,R = {pj | Contig(pj, sj) ∈ Ci,R} are the corresponding set of 
starting positions of the Contigs in Ci,L and Ci,R. 
If the difference between BWCAi,L and BWCAi,R is big, position i is expected to be a 





5.5 The RB-Finder Algorithm to Detect Recombination 
We have presented three techniques to address the main criticisms (accuracy and efficiency) of 
distance-based window methods to detect recombination among two aligned sequences. Next, 
we empirically investigate the effectiveness of our km-distance and BWCA scores to detect 
recombination as opposed to using a conventional distance measure such as the Kronecker delta 
function. Our simulations show that in real datasets where recombination events are more 
complex and harder to detect, our highly sensitive BWCA score stands a better chance of 
detecting the breakpoints than other distance measures.  
We make use of the BWCA score and propose the RB-Finder algorithm to detect 
recombination in a multiple sequence alignment. Given a length-n alignment of M sequences, the 
idea is to move a length-w sliding window along the alignment and, for each position i, computes 
a Recombination Detection Score (RDSi) based on the highly sensitive BWCA score and two key 
observations to differentiate recombination and high mutation rates. At the real breakpoint i, two 
concurrent observations are prevalent: (1) there exists two sequences Sα, Sβ  in the alignment M 
such that the BWCA score increases significantly and suddenly across i, ie BWCAi,L(Sα, Sβ) – 
BWCAi,R(Sα, Sβ) << 0 and (2) there exists yet another sequence Sγ (Sγ ≠ Sβ) such that the BWCA 
score decreases significantly and suddenly across i, ie BWCAi,L(Sα, Sγ) – BWCAi,R(Sα, Sγ) >> 0. 
The first observation is made when there is a transfer of genetic sequence from Sβ to Sα at i 
resulting in a sudden increase in homology between Sα and Sβ. The second observation is that 
after the recombination event at i, Sα is no longer as homologous to some sequence Sγ as 
compared to prior the recombination event. From a phylogeny point of view, the two 
observations are in effect looking for the most divergent branch between the phylogenetic tree in 
[i-w…i-1] and the phylogenetic tree in [i…i+w]. This is shown in Figure 26. 
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Figure 26: Search for most divergent branch in phylogenetic tree across adjacent windows. (a) shows that 
Sα is a recombinant of Sβ at position i to (i+w). (b) shows the phylogenetic trees in [i-w…i-1] and [i…i+w] 
respectively. In [i…i+w], Sα is phylogenetically closer to Sβ, than in [i-w…i-1], resulting in BWCAi,L(Sα, 
Sβ) - BWCAi,R(Sα, Sβ) << 0. Concurrently, Sα is phylogenetically further away from Sγ, resulting in 
BWCAi,L(Sα, Sγ) - BWCAi,R(Sα, Sγ) >> 0. Sα is the most divergent branch between the phylogenetic tree in 
[i-w…i-1] and [i…i+w] and thus detected to most likely contain recombination. 
 
At every putative breakpoint i, we examine each of the M sequences for the two 
observations. Specifically, for each sequence Sα ∈ M at i, we find Contigs with each of the other 
sequences Sβ (Sβ ∈ M and Sα ≠ Sβ) in neighboring windows [i-w…i-1] and [i…i+w]. The KS-test 
is then used to filter sequences whose distributions of contig lengths with Sα in both windows are 
not significantly different at 99% confidence interval. We then compute the BWCA scores of Sα 
with sequences that pass the KS-test in neighboring windows [i-w…i-1] and [i…i+w]. We obtain 
the most significant increase in BWCA score across [i-w…i-1] and [i…i+w] for Sα, that is, 
BWCAi,incr(Sα) = max{BWCAi,R(Sα, Sβ) – BWCAi,L(Sα, Sβ) | Sβ∈ M and  Sα ≠ Sβ}. Similarly, we 
also obtain the most significant decrease in BWCA score across [i-w…i-1] and [i…i+w] for Sα, 
BWCAi,decr(Sα) = max{BWCAi,L(Sα, Sγ) – BWCAi,R(Sα, Sγ) | Sγ∈ M and Sα ≠ Sγ ≠ Sβ}. 
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Subsequently, we compute RDSi(Sα), the recombination detection score for Sα accordingly as 
shown in Table 7: 
 
Scenario Observations Present RDSi(Sα) = Reason 
1 (1) and (2) BWCAi,incr(Sα) * BWCAi,decr(Sα) Recombination 
2 (1) 0 





3 (2) - BWCAi,decr(Sα) High rates of mutation 
4 None 0 No significant change in homology 
 
Table 7:  The formula to compute the RDS for a sequence based on the 2 observations. 
 
Note that scenario 1 produces a distinctly high RDSi(Sα) that indicates Sα has a 
recombination event at position i. On the other hand, scenario 3 produces a negative RDSi(Sα) to 
clearly indicate high mutation rates. The other scenarios are deemed uninteresting in 
recombination detection and assigned RDSi(Sα) = 0. 
Finally, we select the highest RDS among the M sequences to representing the RDS for 
breakpoint i: 
RDSi = max(RDSi (Sα)) 
 
It is easy to see that if RDSi(Sα) < 0 for all Sα ∈ M, then RDSi < 0. This would indicate that the 
region around i suffers from high mutation rates. Conversely, a high RDSi would mean that i is 
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most likely a true recombination breakpoint. We present the pseudo-code for the RB-Finder 
algorithm below in Figure 27. 
 
 
Figure 27: The pseudo-code for RB-Finder algorithm. 
 
5.6 Evaluation of the RB-Finder Algorithm 
Evaluation of our recombination detection algorithm is carried out by applying our algorithm to 
three synthetic and one biological datasets used in two previous papers [64, 65]. The three 
synthetic datasets (SD1, SD2 and SD3) each contains a 5500-bp alignment of eight sequences 
 101
(S1, S2, …., S8) whose evolution was simulated with the Kimura model [119]. For SD1 and SD2, 
two recombination events were simulated: an ancient event affecting the region between sites 
1000 and 1500, and a recent event affecting the region between sites 2500 and 3000. To test 
whether the detection method can successfully differentiate between recombination and rate 
variation, a mutational hotspot between sites 4000 and 4500 was introduced. The average branch 
length of the underlying phylogenetic trees for SD1 and SD2 are 0.1 and 0.01 respectively. The 
third synthetic dataset SD3 contains an ancient event affecting the region between sites 1000 and 
2000, and a recent event between sites 3000 and 4000. The branch lengths of the tree were drawn 
from a uniform distribution on the interval [0.003, 0.005]. SD3 was deliberately created by 
Husmeier et al. [64] to thwart previous algorithms cited in their paper. The biological dataset 
used in our experiment is a length-3049 gap-removed ClustalW [120] alignment of 10 Hepatitis 
B virus sequences. It consists of two recombinant strains (D0329 and X68292) and eight non-
recombinant strains (V00866, M57663, D00330, M54923, X01587, D00630, M32138 and 
L27106). 
We ran our algorithm using (k,m)-mers with k=20 while m is automatically determined 
depending on the point mutation rate, and two window lengths 500 and 600. Note that the 
optimal window length to detect recombination in three of the four datasets (SD1, SD2 and Hep 
B) is 500 since all the recombination events that happened in these three datasets are of span 500 
nucleotides. Thus, a window length of 600 would generate alignment noise and decrease 
accuracy of recombination detection in the three datasets. We shall see from the following results 
that the effects of alignment noise on recombination detection using our algorithm were minimal. 
We compared our results with that from Pruned-PDM since it has the highest accuracy. In 
addition, we also ran our datasets using Recco (default parameters with 1000 iterations), a newly 
 102
developed windowless method, to investigate the effectiveness of non-sliding-window methods 
in detecting recombination in our setting. 
 
 
Figure 28: Recombination analysis results on SD1. Top: Results of our algorithm on SD1 with window 
lengths of 500 and 600. The circles highlight the recombination breakpoints at position 1000, 1500, 2500 
and 3000 respectively. The rectangles highlight the high mutation regions which we detected. Middle: 
Results of Pruned-PDM on SD1 with window lengths of 500 and 600. When w= 600, recombination 
breakpoints at position 1000 and 1500 were detected at 1100 and 1400 instead. There are also multiple 
peaks around position 2500 and 3000. Bottom: Results of Recco showed that breakpoints at 2500 and 
3000 were detected correctly. The breakpoint at 1500 was detected at position 1400. Breakpoint 1000 was 
not detected and the high mutation region around position 5000 was wrongly detected as a breakpoint. 
 
For SD1 and SD2, when we ran our algorithm with window lengths 500 and 600, we 
detected a pair of weak recombination breakpoints at sites 1000 and 1500, and a pair of strong 
recombination breakpoints at sites 2500 and 3000. This is shown in Figure 28 and Figure 29 
respectively. Note that a majority of the scores at sites 4000 to 5000 are less than 0 which is an 
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indication of high mutation rates. Thus, our algorithm also has a nice property of detection high 
mutation rates that may be mistaken for recombination. Pruned-PDM on the other hand produced 
inaccurate breakpoint positions with window size 600 for both datasets. We also ran Recco on 
the two datasets. For SD1, Recco could only detect the weak recombination breakpoint at 
position 1500 and the strong recombination breakpoints at position 2500 and 3000. Breakpoint at 
position 1000 was not detected and the mutation hotspot around position 5000 was wrongly 
detected as a breakpoint. For SD2, Recco could only detect the two strong recombination 
breakpoints. SD3 is a difficult dataset to analyze because there are only subtle differences in the 
alignment. Despite the very low rate of evolution in SD3, our algorithm detected recombination 
breakpoints at sites 1000, 2000, 3000 and 4000. In addition, our algorithm also detected a 
mutational hotspot around site 5000. The results for SD3 using window lengths 500 and 600 are 
shown in Figure 30. This time, Pruned-PDM not only produced inaccurate breakpoints, but also 
failed to detect the breakpoint at position 2000. Recco did not perform well on this dataset and 
could only detect breakpoints at positions 3000 and 4000. 
For the Hepatitis B dataset, we detected three breakpoints around the sites 600, 1700 and 
2200 for window lengths 500 and 600. In addition, we also detected an unreported recombination 
breakpoint around site 1000, which can be found by DSS and Pruned-PDM only when they use a 
window length of 300. The three breakpoints around the sites 600, 1700 and 2200 were also 
found by Recco. However, Recco also detected several other breakpoints which were previously 





Figure 29: Recombination analysis results on SD2. Top: Results of our algorithm on SD2 with window 
lengths of 500 and 600. The circles highlight the recombination breakpoints at position 1000, 1500, 2500 
and 3000 respectively. The rectangles highlight the high mutation regions which we detected. Middle: 
Results of Pruned-PDM on SD2 with window lengths of 500 and 600. When w = 600, the breakpoints are 
inaccurately detected at sites 1100, 1300, 2400 and 3000. Bottom: Results of Recco showed that except 
the strong recombination breakpoints at 2500 and 3000, the rest were not detected. 
 
Our results using the four datasets are consistent with the DSS, Pruned-PDM and 
RECOMP methods. Through the use of our proposed weighting strategy and two key 
recombination-identifying observations, our algorithm is able to compute recombination 
breakpoints of a given alignment in a matter of minutes. Compared to Pruned-PDM which takes 
hours to analyze the same dataset, our algorithm is very much faster and achieves similarly 
accurate results. Unlike RECOMP which gives the user a choice of four graphs to decipher the 
recombination breakpoints, our algorithm generates only a single graph and thus prevents 
ambiguity of deciding which graph best represents the correct recombination breakpoints. An 
 105
example of this ambiguity is shown in their results for the SD3 dataset [65]. In their analysis, 
three of four graphs wrongly indicated that there is a recombination breakpoint at position 5000. 
Hence, it is difficult for the user to correctly infer that the recombination breakpoint detected at 
position 5000 by the three graphs is incorrect based on the remaining graph. In our analysis, we 
correctly identify the region around position 5000 as a mutational hotspot. This example also 
illustrates another advantage that our algorithm has over previous methods. Previous algorithms 
cannot differentiate normal regions from mutation hotspots. A useful feature of our algorithm is 
that it produces a RDS < 0 when the region has a high mutation rate. This immediately provides 
more biological information about the sequences to aid experimental studies. 
 
 
Figure 30: Recombination analysis results on SD3. Top: Results of our algorithm on SD3 with window 
lengths of 500 and 600. The circles highlight the recombination breakpoints at position 1000, 2000, 3000 
and 4000 respectively. The rectangles highlight the high mutation regions which we detected. Middle: 
Results of Pruned-PDM on SD3 with window lengths of 500 and 600. When w = 600, the breakpoint at 
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position 2000 was undetected. Other breakpoints are also inaccurate. Bottom: Results of Recco showed 
that only breakpoints at 3000 and 4000 were detected.  
 
 
Figure 31: Recombination analysis results on Hep B. Top: Results of our algorithm on Hep B with 
window lengths of 500 and 600. The circles highlight the recombination breakpoints at position 600, 1700 
and 2200 respectively. There is an unreported recombination breakpoint at position 1000. Middle: Results 
of Pruned-PDM on SD3 with window lengths of 500 and 600. The breakpoints are also detected at the 
same positions. Bottom: Results of Recco showed that breakpoints at 600, 1700 and 2200 were detected. 
However, there were several unreported breakpoints detected. 
 
From the experiments, it is interesting to see that the non-window method Recco did not 
perform as well as the sliding window methods presented, with respect to the four datasets. 
Recco uses a cost model which tries to reconstruct the recombinant sequence using other 
sequences in the alignment. In regions where there is weak recombination, this reconstruction is 
often thwarted by noise and thus may be extremely difficult. In such cases, sliding window 
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methods which are able to isolate small regions for separate detection analysis may be a better 
alternative. 
 
5.7 Selection of Optimal Shared (k, m)-mers 
Our algorithm uses shared (k,m)-mers to avoid the effect of random point mutations in an 
alignment which improves the accuracy and sensitivity of detecting recombination. Since the 
underlying mutation rate m is automatically determined, the selection of the parameter k used to 
define a shared (k,m)-mer is crucial in achieving optimal performance for our method. When k ≈ 
1, our algorithm is in fact using hamming distance and hence suffers from noise caused by 
random point mutations. On the other hand, if k is too long, it becomes harder to find shared 
(k,m)-mers in the alignment. Consequently, our algorithm loses sensitivity in detecting 
recombination breakpoints.  
To determine the range of k values where our method works optimally, we ran RBFinder 
on dataset SD1 and the more difficult dataset SD2 with different values of k and window size of 
500. From Figure 32, we see that our algorithm performs optimally when k is between 10 and 20. 
When k = 1, our algorithm detects all the recombination breakpoints in SD1 accurately. 
However, the same k did not yield good results when applied on SD2, the dataset with more 
random point mutations. This clearly demonstrates the susceptibility of conventional distance 
metrics such as hamming distance when used in recombination detection. On the other hand, 
when k gets large, our method is less sensitive to subtle local alignment changes. Thus, this 





Figure 32: Results of running RBFinder on dataset SD1 and the more difficult dataset SD2 with different 
values of k for defining shared (k,m)-mers and window size of 500. Our algorithm performs optimally 





5.8 Analysis of Circulating Recombinant Forms of HIV-1 
Acquired Immune Deficiency Syndrome (AIDS) is a worldwide epidemic caused by a virus 
known as human immunodeficiency virus (HIV). Efforts to develop HIV vaccines and medicine 
have been thwarted with difficulties due to the fast mutation and recombination rates of HIV 
[121] There are two types of HIV, namely HIV-1 and HIV-2. HIV-1, which is responsible for 
most human infections, consists of three major groups: M, N and O. The most common group M 
of HIV-1 is further characterized into 9 subtypes (A, B, C, D, F, H, J and K). The ease at which 
HIV-1 subtypes recombine has also resulted in numerous circulating recombinant forms (CRFs) 
of HIV-1 [122]. These CRFs pose more difficulties to finding a cure. Thus, the analysis of 
existing CRFs and the identification of new CRFs will be vital to the efforts against HIV. 
The HIV database (http://www.hiv.lanl.gov/content/hiv-db/mainpage.html) contains a list of 
all existing CRFs to date. Each CRF is classified according to its recombinant subtypes. Eg 
CRF02_AG is a recombinant of subtype A and subtype G. In addition, a graphical representation 
of each CRF in terms of where the recombination occurs at gene level is also available 
(http://hiv-web.lanl.gov/content/hiv-db/CRFs/CRFs.html). From the database, we downloaded 
the sequences of 13 CRFs and 35 reference sequences of the 9 subtypes. Experiments are 
performed in the following manner: 
 
1. For each CRF, download its sequence and several reference sequences of its parent 
subtypes. Align with ClustalW with default parameters. 
2. Run RB-Finder on each alignment. Gaps are not removed because they appear in almost 
all regions of the alignments. Instead, we modified our program so that a length-w sliding 
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window is allowed to have 0.1w gaps. This is to accommodate insertions and deletions in 
our computation of recombination breakpoints. To prevent inaccuracies caused by 
incompletely assemblies, sequences with more than 0.1w gaps in a particular window will 
not be considered. 
3. Identify breakpoints of each CRF and compare with the graphical representation of the 
corresponding CRF. In addition, identify the reference sequences of its parent subtypes 
that contributed to the recombination. 
 
We summarize our findings in Table 8. 
 












CRF02_AG L39106 A,G 9 8 
• Breakpoint at LTR not detected 
because reference sequences at LTR 
is incomplete 
• AF286238 belonging to subtype A 
did not contribute to recombination 
CRF03_AB AF193276 A,B 2 2 • AF286238 belonging to subtype A did not contribute to recombination 
CRF05_DF AF193253 D,F 9 9 • AY371158 belonging to subtype F2 did not contribute to recombination 
CRF10_CD AF289548 C,D 9 9  
CRF12_BF AF385936 B,F 10 7 
• Breakpoint at LTR not detected 
because reference sequences at LTR 
is incomplete 
• 2 short recombinant regions (≈ 100 
bp) resulted in 1 breakpoint each 
instead of 2 
CRF14_BG AF423756 B,G 2 2  
CRF16_A2D AF457060 A2,D 3 2 
• Breakpoint at LTR not detected 
because reference sequences at LTR 
is incomplete 
• None of the reference sequences 
belonging to subtype A1 contributed 
to recombination 
CRF20_BG AY900577 B,G 6 4 • 2 short recombinant regions (≈ 100 bp) resulted in 1 breakpoint each 
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instead of 2 
CRF21_A2D AF457051 A2,D 7 7 
• 3 of 4 of the reference sequences 
belonging to subtype A1 (AF069670, 
AF004885, AF484509) contributed to 
recombination 
CRF23_BG AY900571 B,G 6 5 
• 1 short recombinant region (≈ 150 bp) 
resulted in 1 breakpoint each instead 
of 2 
CRF24_BG AY900574 B,G 6 4 
• 2 short recombinant regions (≈ 100 
bp) resulted in 1 breakpoint each 
instead of 2 
CRF28_BF DQ85873 B,F 2 2 
• None of the reference sequences 
belonging to subtype F2 contributed 
to recombination 
CRF29_BF DQ85876 B,F 4 4 
• None of the reference sequences 
belonging to subtype F2 contributed 
to recombination 
 
Table 8: Results of running RB-Finder on 13 CRFs. 
 
RB-Finder finds almost all breakpoints indicated by the literature, except that when the 
recombination region is too short, RB-Finder reports only one breakpoint for that region instead 
of two breakpoints. Furthermore, using RB-Finder to identify reference sequences of parent 
subtypes that contributed to recombination events in the CRFs yielded some interesting findings. 
Firstly, RB-Finder is able to determine that none of the reference sequences belonging to subtype 
F2 contributed to recombination events in CRF28_BF and CRF29_BF. Subsequently, we found 
that although some CRFs are labeled as a recombinant of two subtypes, not all reference 
sequences of the parent subtypes are involved in the recombination events (Eg CRF02_AG, 
CRF03_AB and CRF05_DF). On the other hand, we also found that some reference sequences 
not in the reported parent subtype of a CRF may be involved in some of its recombination events 
(Eg CRF21_A2D may be a recombinant of subtype A1 as well). This suggests that further 
analysis may be needed to more accurately classify CRFs. Based on the results from RB-Finder, 
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we propose a putative phylogenetic network of the 35 reference sequences belonging to the 9 
subtypes and the 6 CRFs which had irregularities with their subtyping in Figure 33. 
 
 
Figure 33: The proposed putative phylogenetic network of 35 reference sequences of the 9 HIV type M 
subtypes and the 6 CRFs which had irregularities with their subtyping. In the diagram, irregularities are 
presented in red, italic font under their respective CRFs. In addition, the red arrow indicates our proposed 
change in genotyping of CRF05_DF, CRF28_BF and CRF29_BF not to include the subtype F2. The other 




DISCUSSION AND CONCLUSION 
6.1 Practical Implications 
The current genomic age of biology, powered by high-throughput sequencing technologies, has 
brought about an explosion of genomic data. As a result, the number of complete genomes of 
viruses made available in public databases has increased dramatically in recent years.  Despite 
this new wealth of viral genome sequence data, these data has been largely used for evolution 
and epidemiology studies, with little direct clinical application [123]. Therefore, one of the main 
goals of this thesis is to develop technologies and bioinformatics tools that have a greater impact 
on clinical decision-making. For example, our research in tagged-random primer amplification 
has enabled the design of better tagged-random primers that can uniformly and efficiently 
amplify a large number of known viruses, as well as novel and unknown viruses that specific 
primers cannot amplify. Although random primers are generally not as sensitive as specific 
primers, it is likely that well-designed random primers may have sensitivities comparable to that 
of specific primers. 
 In this thesis, we have used microarray technologies to develop two applications of high 
clinical relevance. The first application, a pathogen detection chip, is aimed at providing 
clinicians with a fast and accurate diagnosis using carefully selected oligonucleotide probes from 
hundreds of reported human viruses in a single experiment. This will eliminate unnecessary lab 
tests based on educated guesses from the patient's symptoms and significantly reduce the cost 
and turnaround time of a medical diagnosis.  Furthermore, the pathogen chip with its 
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accompanying statistical software would be able to detect and distinguish a majority of virus 
variants so that the correct treatment can be administered decisively. The second application, a 
resequencing microarray (H1N1 2009), is a cost-effective and viable tool for large-scale 
biosurveillance in the H1N1 2009 pandemic. The accompanying base-calling software 
EvolSTAR has also greatly improved the accuracy and base-calling rate of existing base-calling 
algorithms. Most importantly, our study has highlighted the feasibility of using resequencing 
microarrays for high-throughput full genome sequencing of viruses. In our application, 
resequencing microarrays are relatively low-cost, costing only a 10th that of a 454 run, and 
equivalent to that of a traditional capillary sequencing run. However, through multiplexing, our 
system can generate full genomes of 24 different H1N1(2009) samples in 30 hours. In 
comparison, capillary sequencing and next-generation technologies such as 454 may obtain full 
genomes of only one or two different samples in the same time-frame. 
  Last but not least, we studied the problem of detecting recombination in a set of aligned 
virus sequences. We have identified and addressed the major causes of inaccuracies pertaining to 
sliding window distance-based methods for detecting recombination. The resulting distance-
based algorithm RBFinder is able to achieve accuracies comparable to phylogeny-based 
methods, but requires a much shorter analysis time. This would enable recombination detection 
analysis to be performed on large datasets, which would otherwise be impractical using 






Viruses have the ability to cause devastating pandemics that may result in high morbidity and 
mortality rates. Thus it is imperative that any viral outbreaks be detected and contained as fast as 
possible. The next step would then be to obtain viral genome sequence information that will give 
us important clues on its lineage, epidemiology, drug resistance and possible vaccine 
development. These factors motivated us to develop a number of bioinformatics tools for viral 
detection, resequencing and evolutionary analysis. A summary of the work accomplished in this 
thesis is as follows: 
• In Chapter 2, we studied how the primer efficiency and biases inherent in random PCR 
amplification affect accuracies in PCR-based detection methods. We describe a model 
that predicts the amplification efficiency of a given tagged-random primer on a target 
viral genome. The prediction allows us to filter false-negative probes of the genome that 
lie in regions of poor random PCR amplification and improves the accuracy of pathogen 
detection. Subsequently, we propose LOMA, an algorithm to generate random primers 
that have good amplification efficiency. Wet-lab validation showed that the generated 
random primers improve the amplification efficiency significantly. The blind use of a 
random primer with attached universal tag in a PCR reaction on a pathogen sample may 
not lead to a successful amplification. Thus, the design of tagged-random primers is an 
important consideration when performing PCR. This work has been published in BMC 
Bioinformatics 2008 [124]. 
• In Chapter 3, we investigated the potential of DNA microarrays as “genomic sensors” in 
clinical diagnostics. Biases inherent in random PCR-amplification, cross-hybridization 
 116
effects, and inadequate microarray analysis, however, limit detection sensitivity and 
specificity. We studied the relationships between viral amplification efficiency, 
hybridization signal, and target-probe annealing specificity using a customized 
microarray platform.  Novel features of this platform include the development of a robust 
algorithm that accurately predicts PCR bias during DNA amplification and can be used to 
improve PCR primer design, as well as a powerful statistical concept for inferring 
pathogen identity from probe recognition signatures. Compared to real-time PCR, the 
microarray platform identified pathogens with 94% accuracy (76% sensitivity and 100% 
specificity) in a panel of 36 patient specimens. Our findings show that microarrays can be 
used for the robust and accurate diagnosis of pathogens, and further substantiate the use 
of microarray technology in clinical diagnostics. This work has been published in 
Genome Biology 2007 [125]. 
• In Chapter 4, we developed and field-tested a resequencing kit that is capable of 
interrogating all eight segments of the 2009 influenza A(H1N1) virus genome and its 
variants, with added focus on critical regions such as drug-binding sites, structural 
components and mutation hotspots. The accompanying base-calling software 
(EvolSTAR) introduces novel methods that utilize neighbourhood hybridization intensity 
profiles and substitution bias of probes on the microarray for mutation confirmation and 
recovery of ambiguous base queries. Our results demonstrate that EvolSTAR is highly 
accurate and has a much improved call rate. The high throughput and short turn-around 
time from sample to sequence and analysis results (30 hours for 24 samples) makes this 
kit an efficient large-scale evolutionary biosurveillance tool. This work has been 
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published in Nucleic Acids Research 2010 [126]. An application of our tool has also been 
accepted for publication in New England Journal of Medicine 2010 [127]. 
• In Chapter 5, we developed RB-Finder, a distance-based window method for finding 
recombination breakpoints in a set of alignments. By avoiding the computationally 
expensive and complicated comparisons of phylogenetic trees of phylogeny-based 
methods, our algorithm is faster and thus more scalable to analyze big datasets. 
Moreover, we minimize information loss experienced by conventional distance-based 
methods by introducing a new distance metric that takes into consideration important 
details such as the distribution of mismatches, the number of consecutive matches and the 
locations of common subsequences in an alignment. To improve the accuracy, we 
propose using a weighting strategy that assigns different weights to positions enclosed in 
a window with respect to a putative breakpoint. The idea is to lessen the contribution of 
less important regions of a window when computing a distance measure for the 
alignment. Subsequently, we applied our weighting strategy to our new distance metric 
and describe a fast, simple and intuitive algorithm to detect recombination. Experimental 
results using both simulated and real datasets show that the efficiency and accuracy of 
RB-Finder are better than that of most existing methods. In addition, we present an 
application of RB-Finder in genotyping by analyzing a set of 13 HIV recombinant 
sequences. In our analysis, we detected almost all reported breakpoints of the 13 
sequences and made several novel findings regarding their genotypes. Specifically, we 
found irregularities in the genotyping of six sequences which may trigger new 
considerations when assigning genotypes. This work has been published in RECOMB 
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2007 [128]. The extended version of this work is also published in a special issue of 
Journal of Computational Biology 2008 [129]. 
 
6.3 Future Research Work 
The extensive work presented in this thesis on viral detection, resequencing and evolutionary 
analysis has established a large set of paths for future work. We briefly describe some of our new 
discoveries and research developments below. 
 
6.3.1 Tagged-Random Primer Design with Background Amplification 
Avoidance 
In Chapter 2, we discussed how tagged-random primers can theoretically amplify any sequence 
and hence have a higher chance of successfully amplifying novel, unknown and highly 
mutative/recombinative viruses than specific primers in PCR-based detection methods. However, 
this also means that tagged-random primers can amplify the background human genome and 
cause undesirable cross-hybridization noise. To minimize the background cross-hybridization 
noise, the tagged-random primer should be designed such that it has (1) high AES (amplifies 
well) with the target viral genomes and (2) has low AES (amplifies poorly) with the human 
genome. The challenge here is that it may be difficult to find candidates that amplifies the entire 
human genome poorly. One feasible solution is to only consider regions in the human genome 
where the viral probes on the microarray can cross-hybridize to. Our simulations show that we 
need to consider only one-third of the human genome if such an approach is used. This research 
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direction may pave the way for tagged-random primers with improved specificity and sensitivity 
for viral amplification, as well as background amplification avoidance capabilities. 
 
6.3.2 New Generation Pathogen Chip 
In Chapter 3, the pathogen chip consists of probes selected from the refSeq (as indicated by 
NCBI) of a target set of virus genomes. However, this was found to be not representative of a 
virus genome. There are often multiple genomes of a particular virus because various sequencing 
centres deposit complete and partial sequences of the same virus genome into GenBank. 
Using the most current NT and RefSeq database to date (Feb 2010) in GenBank, we 
downloaded all complete genomes, complete sequences and complete cds and genes of 153 
human viruses of interest. In total, 25177 sequences were obtained for the 153 viruses. A 
homology analysis of the sequences of individual viruses revealed the following: 
• For most of the 153 viruses, there are multiple complete genomes. The most recent 
submission to GenBank is assigned as the reference genome for the virus. 
• There are SNPs among different genomes of the same virus. They may be mutations or 
sequencing errors. 
• It is expected that genomes belonging to different strains of a particular virus may differ 
greatly. However, we found that genomes belonging to the same virus without any 
previously reported strains may also differ greatly. This may be unreported strains of the 
virus residing in different parts of the world. It can also be that the same virus underwent 
independent evolutions. 
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The findings have a serious implication on probe selection for the pathogen chip. Probes selected 
based on a reference genome for a particular virus have a high chance of failing. These probes 
may detect one strain of a virus but not the other. 
To avoid the above problem, for each virus, we cluster all the sequences available based 
on homology. Note that this clustering is blind to strain typing. We cluster sequences that have at 
least 98% homology with one another (performed by BLAST). This will ensure that we identify 
all subgroups of a virus based on homology. We then align all sequences in each subgroup and 
obtain the consensus sequence. The consensus sequences of the subgroups of a virus will then be 
collectively taken to represent the virus. In each alignment, we can also identify suspicious 
regions where the bases are not consistent. These regions may be mutagenic regions or prone to 
sequencing or base-calling errors. Thus, probes will not be selected from such regions to 
minimize the risk of failure. Subgrouping the 25177 sequences belonging to 153 viruses resulted 
in 7790 subgroups. 5677 subgroups are singletons while the remaining 2113 subgroups had more 
than one sequence each. In total, 19500 sequences were able to be clustered. 
Due to the number of subgroups that each virus has, probes that cover the most subgroups 
are preferred for selection. In addition, probes that are unique to a subgroup are also important as 
they may help to differentiate the subgroups if needed. The location of the probes may also be 
important. Consecutive probes lighting up may be an indication that the fragment that the probes 
reside in is present. This may help in identifying recombinations or detecting the virus even 




6.3.3 Pan-Influenza Resequencing Microarray 
In Chapter 4, we have presented a novel approach to obtain the full genome sequence (all 8 
segments) of an influenza virus (H1N1 2009) using resequencing microarrays. However, as 
influenza viruses continuously evolve through mutations and reassortments, we need to 
periodically update (at least annually) our resequencing microarrays with sequence information 
from new variants. One solution is to create a pan-influenza resequencing microarray consisting 
of full genome sequence information from all recent (e.g. 2005 and newer) 
human/avian/mammalian influenza virus strains. Unfortunately, a naïve 1bp resolution tiling 
approach would be infeasible for such a resequencing microarray. Instead, a minimal set of 
probes that covers all target sequences would have to be selected and put on the array. A 
sophisticated assembly algorithm would then be needed to reconstruct high confidence sequence 
calls from the selected probes. A major advantage of this pan-influenza resequencing microarray 
is that it would have a much longer shelf life than existing influenza resequencing microarrays.  
 
6.3.4 Recombination Detection Without Multiple Sequence Alignment 
In Chapter 5, we note that most recombination detection methods require a multiple alignment of 
the input sequences as an initial step. This is problematic in several aspects. First and foremost, 
obtaining the multiple sequence alignment of a set of sequences is slow. The exact solution to the 
multiple sequence alignment problem is NP-complete [130]. Specifically, it takes O(nk) time to 
align k sequences of length n. Hence, heuristic and approximation approaches that seek a 
multiple alignment that maximizes some alignment score are adopted. One of the most popular 
algorithm for multiple sequence alignment is CLUSTALW. It uses a strategy known as 
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progressive alignment and runs in O(k2n2) time. Another multiple sequence alignment program, 
T-Coffee [131], is more accurate than CLUSTALW but is also much slower. Later, MUSCLE 
[132] was developed that outperforms both CLUSTALW and T-Coffee in terms of speed and 
accuracy. However, the inability to scale of current multiple sequence alignment algorithms 
presents an obstacle for recombination analysis involving a large number of sequences. 
Secondly, the multiple sequence alignment of sequences may be inaccurate. 
Misalignments can occur due to various reasons such as using suboptimal scoring parameters. 
The accuracy of the alignment may be even more compromised when analyzing highly evolving 
microorganisms. These microorganisms exhibit high levels of intragenic recombination 
following horizontal gene transfer events, resulting in mosaic-like sequences. Unless these 
sequences have high homology with one another in similar genomic regions, multiple sequence 
alignments may be difficult or impossible to attain. Consequently, important recombination 
events may be lost in the erroneous alignment. Furthermore, multiple alignments of sequences of 
different lengths must necessarily add gaps, which often lead to loss of information and gap 
scoring artifacts, which in turn distort the distance computations and phylogeny constructions. 
There is also a risk that these gaps, which are almost always ignored by recombination detection 
algorithms, contain information about recombination events involving duplications and 
transpositions. In many cases, multiple sequence alignments have to be manually refined to 
improve their accuracy. 
To overcome the problem of using multiple sequence alignments, BLAST-Miner [133] 
was developed. It is a BLAST-based method that finds short segments of highly similar 
sequences among the sequences and uses them to identify sequence duplications, insertions, and 
rearrangements. One major disadvantage is that this approach cannot detect recombination 
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events among highly homologous sequences. Another drawback is that the authors only gave a 
graphical representation of all possible recombination events identified but failed to quantify 
them. Nonetheless, this approach provides an insight of how we can avoid using multiple 
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